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ABSTRACT 
GOLFER EXPOSURE TO PESTICIDES 
SEPTEMBER 2017 
JEFFERY J. DOHERTY 
B.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
 
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
 
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
 
Directed by: Professor John Marshall Clark 
 
     There is concern among industry regulators, turfgrass managers, and the general public over 
human exposure to pesticides following their application to turfgrass. The residential aspect of 
turfgrass applications raises concerns about exposure to infants and children, as well as adults. 
To accurately determine the exposure of golfers to turfgrass pesticides, it is necessary to 
understand their transfer and absorption dynamics, as well as the routes of golfer exposure. 
Previous research has demonstrated that exposure to some turfgrass pesticides is at a level that 
would concern USEPA risk assessors using the USEPA Hazard Quotient (HQ) criteria (1). This 
current research used environmental monitoring (dislodgeable foliar residue), dosimetry 
(residues on cotton suits, gloves and personal air samplers) and biomonitoring (quantifying 
pesticide parent compound or metabolites in urine) to determine absorbed dose as well as 
transfer and absorption dynamics, resulting in an estimation of risk to the golfers. It was 
determined that the hands (48.6-70.6%) and lower legs (20-46.2%) received the majority of the 
dose. Airborne residues of these current use pesticides contributed very little to the overall 
dose. Reduced risk pesticides were compared to conventional pesticides, and found to reduce 
golfer hazard. Exposure to all the pesticides studied was well below any level of concern as 
determined by the USEPA using the HQ and Margin of Exposure (MOE) methods. HQs > 1.0 or 
vii 
 
MOEs < 100-300 give rise to a level of concern about possibly unsafe exposures. Acute HQs 
determined by dosimetry ranged from 0.0000008 (carfentrazone-ethyl) to 0.0027 (cyfluthrin), 
while acute MOEs ranged from 125,000,000 (carfentrazone-ethyl) to 47,170 (cyfluthrin), 
indicating limited concern from these exposures. 
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CHAPTER 1 
INTRODUCTION AND LITERATURE REVIEW 
1.1 Importance of Golfer Exposure Studies  
     Golf remains a popular activity, with 26.88 million golfers playing 465.5 million rounds in 
2014 (2) and golf courses cover an estimated 909,027 ha, 67% of which (609,205 ha) is managed 
turfgrass (3).  Maintaining the course to American golfer standards, however, requires the input 
of a wide range of pesticides, such as insecticides, fungicides, herbicides, and plant growth 
regulators (4). The use of pesticides on golf courses raises concerns about direct golfer exposure 
and indirect human exposure through off-site movement as airborne drift or in 
waterways/groundwater. Pesticide exposures are likely to occur to golfers, so there is concern 
both in the turfgrass industry and among industry regulators and the general public. To assess 
the magnitude and duration of exposure to pesticides from golf, it is necessary to determine the 
amount of residues available from contact, how much of these residues are transferred to the 
golfer during the play of golf, and the routes of exposure (inhalation, dermal, and regions of the 
body most exposed). 
1.2 Hazard Assessment 
     Hazard quotients (HQ) are one way to assess risk. Briefly, the USEPA selects a Lowest 
Observable Adverse Effect Level (LOAEL) based on the toxicological study that produced the 
highest LOAEL. This value is then divided by one or more safety/uncertainty factors to establish 
a reference dose (RfD), in µg/kg/day. Once an absorbed dose is determined, it is divided by the 
RfD resulting in an HQ. If the absorbed dose is equal to the RfD, then the HQ = 1, the point at 
which a dose becomes a toxicological concern. It is important to note that HQs > 1 do not 
indicate that adverse effects will occur, only that the absence of adverse effects is less certain.       
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The USEPA has shifted to using Margin of Exposure (MOE) for risk assessment. This analysis 
simply divides the LOAEL by the absorbed dose. Uncertainty and safety factors are taken into 
account when establishing a level of concern (LOC). Pesticide exposures become a concern 
when LOCs are 100-300, depending on the safety/uncertainty and factors used. In practice, LOCs 
<1000 start to raise concerns about an exposure. 
1.3 Golfer Exposure 
     While there is substantial research on pesticide exposure among applicators (5,6) and 
harvesters (7,8), there is scant experimental data available assessing the exposure of golfers to 
pesticides. Murphy and Haith (9) estimated exposure by modelling inhalation of turfgrass 
pesticides.  Putnam et al. (10) determined exposure and hazard to golfers following the 
application of chlorpyrifos and carbaryl, resulting in hazard quotients of 0.0318 and 0.054 
respectively, as determined by biomonitoring. These older, neurotoxic chemicals have high 
application rates, relatively high acute mammalian toxicities and, in the case of chlorpyrifos, 
some measure of volatility.  There is no information on the risks posed to golfers from 
herbicides and fungicides, or newer insecticides with lower mammalian toxicity. The purpose of 
this research is to fill in these information gaps in the data regarding golfer exposure to 
pesticides. 
     Golfer exposure is unlike that of applicators and harvesters. Applicators deal with 
concentrated pesticide formulations, and must wear personal protective equipment, often 
including Tyvec® suits, non-permeable gloves, and respirators. Harvesters may also have 
personal protective equipment, though it is usually less cumbersome as they are dealing with 
much lower concentrations of pesticide due to dilution. They are also protected by a re-entry 
interval. 
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     While golfer exposure may be similar to agricultural workers, the nature of the treated area 
and the activities of the exposed population are different. Turfgrass is a perennial crop, 
developing a thatch layer at the soil surface. This thatch layer readily binds pesticides due to its 
high surface area and organic content (11). Harvesters work in intimate contact with the plants, 
repeatedly contacting treated crops. The region of the golfer that has the most contact with the 
treated turf is the foot, which is protected by shoe. Hands, and sometimes knees contact the 
treated turf only occasionally. Therefore, it is necessary to determine the extent of the exposure 
to pesticides applied to turf that an individual receives during the play of a 18-hole round of golf. 
1.4 Re-entry Intervals 
     In most cropping situations, there is a re-entry interval, the time between the end of the 
application and the point at which workers can re-enter the field or greenhouse. These re-entry 
intervals can vary depending upon the activity the worker is performing, e.g., there may be a 
longer interval for harvesting as opposed to irrigating, where there is minimal contact with the 
treated crop. Canadian pesticide labels mandate a re-entry interval following applications to golf 
courses, listing either a time period (4 or 12 hours) or “until residues have dried” (12). Many 
strategies are used in Canada to comply with this re-entry interval such as using “maintenance 
days” where the course is closed for one day weekly, or opens late/closes early, closing nine 
holes on an 18-hole course, using temporary greens when greens have been treated, and 
treating one set of tees while they apply pesticides to the other (12). For pesticides whose 
Canadian labels prohibit entry “until residues have dried”, strategies include spraying on days 
that provide optimum conditions for drying, and removing dew from greens to reduce drying 
time (12). There is no re-entry interval on American courses. In theory and in practice, golfers 
can play directly behind the pesticide application 
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          The Food Quality Protection Act of 1996 (13) changed the way that USEPA looked at 
exposure to pesticides.  The principle focus of this act was to improve the assessment of 
pesticide exposure by determining the non-dietary exposure (residential, occupational) and 
adding this to the dietary exposure to determine a cumulative risk. This act also required the 
EPA to combine exposures to pesticides with a common mechanism of toxicity (i.e. all 
pyrethroids have a common mechanism of toxicity, so all pyrethroid exposure is combined into 
a single “risk cup”) (13). This accumulation approach changed the previous approach of 
regulating exposures on a chemical by chemical basis (14), ignoring the fact that all 
organaphosphates, for example, are acetylcholinesterase inhibitors, and work at the same site 
of action.  
1.5 Regulatory Background for the Risk Assessment of Pesticides 
      The USEPA uses a 4-step process for assessing risk to humans developed by the National 
Research Council (15). This process begins by identifying whether or not exposure to a chemical 
comes with the risk of adverse effects. If exposure to a compound is determined to carry some 
risk, an exposure assessment is done to assess the magnitude, frequency and duration of 
exposures. Parallel to this, a dose response relationship is established to determine what level 
of exposure leads to adverse effects. Once these two factors are determined, the risk is 
characterized by determining the estimated incidence of adverse effects in a population, and 
what extra health problems are expected to arise from this exposure. Since direct human 
exposure data is frequently unavailable, the USEPA uses models or various surrogate exposure 
values to estimate potential exposures (16). The models typically use environmental residues, 
the activities performed, and the absorption mechanism (inhalation, dermal, oral) (16). 
Depending on the parameters input, a model can result in exposure estimates that vary by 
several orders of magnitude (14). 
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1.6 Dermal Exposure 
     Exposure to treated turf is principally through the dermal route, by contacting Dislodgeable 
Foliar Residues (DFR) present in the treated turfgrass system (17). Unlike traditional cropping 
systems where a significant amount of the applied pesticide reaches the bare soil, the dense 
canopy provided by turfgrass intercepts much of the applied pesticide before it reaches the soil, 
possibly increasing volatile and DFR in a given area (1,18). This potential increase in available 
inhalation and dermal exposure may be diminished based on certain characteristics of the 
turfgrass system. Turfgrasses, like most plants, have a substantial waxy layer on the leaves, 
which can absorb the relatively non-polar pesticides. Additionally, between the soil surface and 
the crowns of the turfgrass exists a thatch layer made up of partially decayed root and shoot 
tissue, which can be quite thick. This thatch layer has a high organic carbon content, and the 
capacity to absorb pesticides (11). The combination of the waxy layer and the thatch may help 
reduce exposure through adsorption, making the pesticides unavailable for transfer. 
     The skin is a fairly effective barrier against the absorption of pesticides. In order to reach the 
highly vasculated dermis and thus general circulation, a chemical must pass through numerous 
layers of dead, keratinized cells (19). Dermal absorption of pesticides occurs by passive 
transport, and the mechanism by which it is transported depends on its concentration and 
chemical polarity. Relatively more polar, water soluble pesticides (e.g. plant growth regulators) 
diffuse through the hydrated stratum corneum, and non-polar pesticides move through the non-
polar lipid matrix of the membrane itself (20). Small molecules tend to move through the skin 
faster than larger molecules (19). In general, non-polar, lipid soluble compounds are better able 
to penetrate the dermis. Pesticides of intermediate polarity are termed amphipathic. The skin is 
not composed only of dead cells, but contains many skin appendages such as sebaceous glands 
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and hair follicles. These functional appendages of the skin provide additional pathways for the 
penetration of non-polar and amphipathic pesticides, respectively. 
1.7 Inhalation exposure 
     Compounds with vapor pressures less than 0.013 mPa are considered relatively non-volatile, 
and the pesticides used in this study all fit this profile, with vapor pressures ranging from 3.0 x 
10-12 mPa at 20°C (imidacloprid) to < 0.013 mPa at 20°C (halofenozide) (21). It is therefore 
unlikely that a significant amount of any of these pesticides would be picked up by the personal 
air samplers as volatiles. It is more likely that they were present as aerosols or sorbed to dust 
particles. Particles with aerodynamic diameters <10 µm can penetrate conducting airways, and 
particulates <2.5 µm can enter the gas exchanging regions of the lungs (alveoli), and can be 
considered a true inhaled dose (22). Particles between 2.5 and 10 µm can be absorbed through 
the trachea, while larger particles may be trapped by the cilia and mucus membranes in the 
esophagus and swallowed, essentially an oral dose. Human alveoli have membranes with a 
harmonic mean of ~0.6 µm (23), and are adjacent to a large number of capillaries so pesticides 
can easily pass into systemic circulation through passive transport. In regulatory toxicology, 
100% of the inhaled dose is assumed to enter circulation. Additionally, pesticides that enter 
circulation through the lungs bypass the liver, the major site of detoxification and excretion 
conjugation reactions in the human body. Dust particles can vary in size from 0.001 to 40 µm 
(24), with the composition varying widely depending on geographic location and environmental 
conditions. It is impossible to determine the particle size distribution under the experimental 
conditions, so it is prudent to assume that 100% of the inhaled dose is absorbed.  
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1.8 Oral Exposure 
     Oral exposure is the least likely route of golfer exposure, and is not considered in this study. 
There is some evidence that golf equipment (balls, tees, etc.) do not pick up large amounts of 
pesticides, and do not efficiently transfer these residues (25). Nonetheless, there is most likely 
some oral exposure through hand to mouth contact. While no one smoked during the 
experiment (significant hand to mouth contact), volunteers were provided snacks and drinks 
midway through their exposure. It is very difficult to quantify exposure through this route. 
However, this type of exposure would be captured in the biomonitoring approach discussed 
below. 
1.9 Environmental Residues 
     Inhalation hazard associated with golfing has been assessed by both high-volume and 
personal air samplers (1,10,18) with Putnam et al. (10) finding good correlation between the 
two methods. The use of personal air samplers may be more appropriate, due to their 
positioning very close to the breathing zone. 
     Dermal exposure is correlated with DFR of pesticides on the treated foliage (17,25). Once a 
pesticide is deposited on the turf, it may volatilize (disperse into the air), move into the waxy 
layer of the plant, or move down into the thatch and soil (leach). While volatilization initially 
increases exposure, anything not inhaled is dispersed into the atmosphere. Thus, all these 
processes reduce availability of the pesticide for exposure. The remaining pesticide on the 
foliage is referred to as DFR, pesticide that is easily dislodged from the foliar surface. Several 
techniques have been used to determine DFR in turf, including foliar washing (27), hand wipes 
of a defined surface area (1), and the California Roller, a standardized weighted roller used to 
facilitate the transfer of the DFR to a cotton cloth (28,29,30). The California Roller has become 
the preferred method for evaluating DFR from turfgrass. 
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     Using only environmental residues to determine exposure is fraught with difficulties, and may 
underestimate or overestimate the dose. It often fails to take into account differences in human 
behaviors, both between different activities (e.g. golf vs soccer), or within an activity such as 
golf. Despite our best efforts to establish a repeatable, choreographed routine among our 
volunteer golfers during play, it became clear that individual human behavior impacted the dose 
received. Certain individuals had consistently higher (or lower) exposure to certain body parts. 
These variables are inherently difficult to model, and experimental data on these variables do 
not exist. Frequently, default assumptions are used in risk assessment (31). 
1.10 Dosimetry 
     Dosimetry is useful in measuring transferrable residues (pesticides transferred from the turf 
to the golfer). DFR simply measure environmental concentrations, which are principally 
influenced by formulation, application rate, chemical properties and the type of surface treated. 
Transferrable residues imply a specific activity (e.g., golf), and the residues transferred by 
performing this activity in a pesticide-treated area. Dosimeters (a physical matrix to collect DFR) 
used include clothing or cloth patches (26, 39-42). They serve as a passive medium to collect 
DFR from treated surfaces. The ratio between the DFR and the amount determined on the 
dosimeter is considered the transfer factor for one particular pesticide during that specific 
activity (39). Chlorpyrifos and allethrin have been shown to have different transfer factors from 
the same surface (42) and the amount transferred decreases after initial contact. It is possible 
that the pesticide is absorbed/adsorbed to the treated surface, degrades or volatilizes. Most 
likely, the pesticide is removed on initial contact. 
1.11 Biomonitoring 
     Biomonitoring (analysis of biological samples in exposed subjects, typically urine or blood) is 
the preferred method of determining exposure because it avoids making any assumptions about 
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behavior, pesticide transfer dynamics, or any penetration factors, and most likely represents the 
relevant dose (32-34). If the pharmacokinetics (absorption, distribution, metabolism and 
excretion) is known, biomonitoring is the most reliable way of determining dose when suitable 
biomarkers (either major metabolites or parent compound) are present (35-37). However, the 
pharmacokinetics of a pesticide, particularly newer ones, are determined in species other than 
humans, and pharmacokinetics (like toxicity) can vary greatly both between and within species. 
Older pesticides such as 2,4-D, have pharmacokinetic data derived from human studies, and this 
data is more reliable in determining dose.   
     Measuring urinary biomarkers is the simplest way of determining the absorbed dose of a 
pesticide. Once the concentration of a biomarker in urine is known, pharmacokinetic data on 
absorption, distribution, metabolism and excretion can be used to back calculate to the 
absorbed dose. Biomarkers in blood are useful and often used in ecotoxicology studies, 
however, humans blood draws are invasive, highly regulated, time consuming, and expensive 
and frequently result in a small sample volume. 
     Modern pesticides are generally rapidly and extensively metabolized and often have short 
half-lives in the body, leading to a possible underestimation of exposure. Biomonitoring also 
cannot determine the source or frequency of an exposure. It is impossible to determine through 
biomonitoring whether a dose is from a large single exposure or multiple small exposures. For 
these reasons, the best approach is to use biomonitoring in conjunction with concurrently 
collected environmental samples (31, 38). 
1.12 Pesticides 
     Pesticides were chosen based on the following criteria: 1) turfgrass pesticides that are widely 
used in the northeastern US; 2) include  fungicides, herbicides, and insecticides; 3) include 
reduced risk compounds, exhibiting lower mammalian toxicity, lower use rates, and lessened 
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environmental impact; 4) include a wide range of physical and chemical properties that 
influence their environmental behavior and thereby exposure including water solubility, 
application rate, vapor pressure and inherent toxicity. Pesticides used and their physicochemical 
properties are listed in Table 1.  
Table 1. Physical properties of the pesticides listed in order of increasing water solubility. 
 
Compound MW VP (mPa,20°C) 
WS 
(mg/l) 
*Koc 
Kow 
(logP) 
pKa 
App. 
Rate 
Cyfluthrin 434.3 1.4-8.5 x 10-5  0.0019 > 3700 5.9 NA 1.5g 
Chlorothalonil 265.9 5.7 x 10-7 0.81 >5000 2.92 NA 118g 
Azoxystrobin 403.4 1.1 x 10-7 6.7 207-594 2.5 NA 5.7g 
Carfentrazone-ethyl 412.2 0.0072 12 750 3.36 NA 0.99g 
Halofenozide 330.8 <0.013 12.3 224-279 3.22 NA 18.4g 
Imidacloprid 255.7 3.0 x 10-12 610 156-800 0.57 11.1 4.2g 
MCPP-p 214.6 1.2 x 10-5 860 5-43 0.02 3.78 3.8g 
2,4-D 221.0 1.4x 10-7 23180 20-136 0.177 2.73 2.4g 
From MacBean C, ed; e-Pesticide Manual. 15th ed., ver. 5.1, Alton, UK; British Crop Protection 
Council except *Koc from pubchem.ncbi.nlm.nih.gov. App Rate, application rate/1000 ft2). 
 
      Fungicides (azoxystrobin, chlorothalonil), herbicides (carfentrazone-ethyl, 2,4-D, MCPP-p), 
and insecticides (cyfluthrin, halofenozide, imidacloprid) are all represented in the pesticides 
studied. The reduced risk compounds studies include a fungicide, (azoxystrobin), an herbicide 
(carfentrazone-ethyl), and an insecticide (halofenozide). Vapor pressures range from 3.0 x 10-12 
(imidacloprid) to <0.013 (halofenozide), >4,000,000,000-fold difference, water solubility ranges 
from 0.0019 mg/l (cyfluthrin) to 23,180 mg/l (2,4-D), 1,220,000-fold difference, and Kows range 
from 0.02 (MCPP-p) to 3.36 (carfentrazone ethyl), 168-24fold difference. Application rates range 
from 0.99g/1000 ft2 (carfentrazone-ethyl) to 118g/1000ft2 (chlorothalonil), 120-fold difference. 
Acute No Observable Adverse Effects Levels (NOAELs) range from 2500 µg/kg/d (cyfluthrin, a 
neurotoxic insecticide) to 500,000 µg/kg/d (carfentrazone-ethyl, a reduced risk herbicide), a 
200-fold difference.  
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    The pesticides studies include two neurotoxic insecticides, cyfluthrin and imidacloprid. 
Cyfluthrin, a pyrethroid, selectively targets insect voltage gated sodium channels and possibly 
calcium channels. This selectivity has been ascribed to rapid mammalian metabolism, lower 
sensitivity of the mammalian sodium channel, and inefficient uptake of pyrethroids through 
some routes (43). Insect sodium channels are more than an order of magnitude more sensitive 
to cismethrin a pyrethroid, than mammalian sodium channels (44). Imidacloprid exhibits 
selectivity to insects over mammals through poor binding to the mammalian nicotinic 
acetylcholine receptor (nAChR) and is highly selective for the insect nAChR (45). Imidacloprid 
binds to the fruit fly nAChR with 565-fold greater affinity than to the mouse nAChR, and is 900-
fold more toxic to fruit fly than mouse (46). The third insecticide evaluated, halofenozide, is not 
a neurotoxin but an ecdysone inhibitor. This class of compounds interferes with insect molting, a 
physiological process not found in mammals. The fungicides and herbicides in this study target 
receptors or physiological processes not found in mammals, and therefore generally have low 
mammalian toxicity. 
1.13 NOAELs, Acute Reference Doses and Margins of Exposure 
     No Observed Adverse Effect Levels (NOAELs) are based on toxicity studies that determine a 
dose at which no adverse effects are seen. This value is reported in mg of the substance tested 
per kg of body weight. Acute NOAELs are used in this research because golfer exposure is 
expected to be episodic, and it is unlikely that an individual would be exposed to these turfgrass 
pesticides more than once every 24-96 hours. The toxicity studies expose test animals to a range 
of single doses, and the highest dose at which no adverse effects are seen is defined as the 
NOAEL. These data are usually generated through oral administration of the test pesticide. Since 
golfer exposure is primarily dermal, NOAELs generated through dermal exposure are used when 
available. 
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     Reference doses (RfD) are estimated by the USEPA using these NOAEL values. RfDs are then 
modified by one or more safety factors. Uncertainty Factor A (UFA) is used to take into 
consideration interspecies differences, while Uncertainty Factor H (UFH) takes into consideration 
the intraspecies differences found in humans. These factors are 10X each, so the NOAEL is 
typically divided by 100 to arrive at the RfD. Some pesticides also have a Food Quality Protection 
Act Safety Factor (FQPASF) of 3X for the protection of vulnerable populations such as infants, 
children, and pregnant women. In effect, the NOAEL is divided by 10-300, with the most 
common modification 100X. The absorbed dose of a pesticide is divided by this RfD the generate 
a hazard quotient (HQ, Eqn.1). Hazard quotients > 1.0 imply a concern with that exposure. 
Eqn 1.       
𝐷𝑜𝑠ⅇ
𝑅𝑓𝐷
= 𝐻𝑄 
     Margin of Exposure (MOE) is also calculated from the NOAEL, but no safety factors are used. 
Instead, the NOAEL is simply divided by the absorbed dose (Eqn 2). Safety factors are taken into 
account when establishing a Level of Concern (LOC). If a pesticide is assigned a UFA and UFH, 
concerns arise when the MOE is less than 100. If a FQPASF (3X) is used, the LOC for that 
compound is 300. In practice, concerns typically arise when a MOE < 1000. 
Eqn 2.       
𝑁𝑂𝐴𝐸𝐿
𝐷𝑜𝑠ⅇ
= 𝑀𝑂𝐸 
 
1.14 Previous Research 
 
     Turfgrass pesticides with high vapor pressures and high mammalian toxicities have been 
shown to result in hazard quotients > 1.0 (MOE < 100), indicating concern with these exposures. 
Organophosphate insecticides, with relatively high mammalian toxicity and some volatility, were 
of particular concern (1, 18). Clark et al. (18) found 5 of 14 turfgrass pesticides studied had 
combined dermal and inhalation HQs > 1.0. All were organophosphates (ethoprop, isazofos, 
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diazinon, isofenphos and chlorpyrifos), and all received post-application irrigation. The sampling 
period roughly equates to the time required to play a round of golf (a 4-hour sampling time for 
inhaled dose, 5-hour sampling time for DFR). These pesticides were subsequently removed from 
use on turfgrass, although chlorpyrifos has recently had some turf uses reinstated. It was 
determined that vapor pressures > 0.013 mPa and high inherent mammalian toxicity (low RfD) 
were the driving factors that resulted in HQs >1.0. Current use pesticides examined in this 
research all had vapor pressures > 0.013, and comparatively high RfDs.  
     Many methods have been employed to attempt to mitigate pesticide exposure from treated 
turf. Spray adjuvants Aqua Gro L (wetting agent) and Exalt 800 (spreader sticker), and 
dethatching were utilized in an attempt to reduce airborne concentrations and DFR, but had no 
effect on these residues (18). They are therefore unlikely to reduce exposure.  
     Similar research found that Silwet L-77 was ineffective in reducing airborne concentrations 
and DFR, while increasing post-application irrigation from 0.63 to 1.3 cm reduced HQs by ~ 4-
fold (47). The use of post-application irrigation is dependent on the target pest, however, and is 
only used for subsurface insect pests, fungi, and pre-emergent herbicides. Thus, this 
management strategy is not always available. Additionally, golf courses are under a great deal of 
pressure to reduce water use, and increasing irrigation is not without its cost. Many courses 
have strict limits on the amount of water they can draw from a source, so any irrigation used to 
water in pesticides reduces the amount available when it may be needed to reduce drought 
stress. Partial course application strategies (half-course applications, applications only to tees 
and greens) have also been evaluated for reducing exposure to turfgrass pesticides (48). 
Applications to tees and greens reduced both dosimetry residues (76-81%) and airborne 
residues (75-84%), while ½ course applications reduced dosimetry residues by ~30% (8). Thus, 
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applications to tees and greens, or partial course applications are the most effective means of 
reducing golfer exposure to pesticides. 
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CHAPTER 2 
MATERIALS AND METHODS 
 
2.1 Chemicals and Reagents 
    Imidacloprid (N-[1-[(6-chloropyridin-3-yl)methyl]-4,5-dihydroimidazol-2-yl]nitramide), 
chlorothalonil (2,4,5,6-tetrachloroisophthalonitrile), 2,4-D (2,4-dichlorophenoxyacetic acid), 
MCPP-p (2R)-2-(4-chloro-2-methylphenoxy)propanoic acid), dicamba (3,6-Dichloro-2-
methoxybenzoic acid), azoxystrobin (methyl 
(E)-2-{2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate), carfentrazone-ethyl 
(ethyl 2-chloro-3-[2-chloro-5-[4-(difluoromethyl)-3-methyl-5-oxo-1,2,4-triazol-1-yl]-4-
fluorophenyl]propanoate) and halofenozide (N'-benzoyl-N'-tert-butyl-4-chlorobenzohydrazide) 
analytical standards were supplied by the US EPA National Pesticide Standard Repository, Fort 
Mead, MD. The imidacloprid metabolite 6-chloronicotinic acid and isotopically labeled 13C,D3-
imidacloprid were a generous gift from Bayer Corp., Kansas City MO. Pesticide formulations of 
imidacloprid (Merit 75 WP), chlorothalonil (Manicure Ultra), 2,4-D, dicamba, and MCPP-p 
(Trimec), azoxystrobin (Heritage, carfentrazone-ethyl (Quicksilver T&O) and halofenozide (Mach 
II SC) were purchased commercially (Valley Green, Holyoke, MA). All solvents used in this project 
were pesticide residue grade or better. All reagents used were ACS grade or better, and all 
water was deionized to achieve a resistivity of 18.2 MΩ (RIOS 5, Milli-Q Academic, EMD 
Millipore, Billerica, MA). Pesticide structures are shown below (Fig. 1). 
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Figure 1: Structures of the pesticides. 
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2.2 Pesticide Applications 
     A Toro Multipro 1200 boom sprayer fitted with eleven VisiFlo® flat spray tips (TeeJet® 
Technologies) was used for all applications. All treatments with Mach II 2SC® (halofenozide, 
Syngenta) and Merit 75 WP (imidacloprid, Bayer) were followed by 0.64 cm (0.25-inch) of 
irrigation immediately after application. All pesticides were applied in 2 gallons water/1000 ft2 
(7.6 L/93 m2). 
    Manicure Ultrex (82.5% chlorothalonil, Lesco Inc.) was applied at the USEPA maximum label 
rate of rate of 12.7 kg a.i./ha. 12.7 lb. of formulated product was mixed with 80 gallons of water 
(5.8 kg formulation in 302.8L). 
     The components of Trimec Bentgrass Formula (6.12% 2,4-D, 9.92% MCPP-p, 2.53% dicamba, 
PBI Gordon) were applied at the USEPA maximum label rates of 0.26 kg/ha (2,4-D), 0.41 kg/ha 
(MCPP-p), and 0.09 kg/ha (dicamba). For Trimec Bentgrass Formulation, 7.7 fluid ounces of 
formulated product was mixed with 80 gallons of water (224 ml formulation in 302.8L). 
     Merit 75 WP (75% imidacloprid, Bayer) was applied at the USEPA maximum label rate of 0.45 
kg a.i./ha. For Merit, 7.9 ounces of formulated product was mixed with 80 gallons of water (224 
g formulation in 302.8L).  
     Tempo 20 WP (20% cyfluthrin, Bayer Corp., Kansas City, MO) was applied at the USEPA 
maximum label rate of 0.14 kg a.i./ha. For Tempo, 55 grams of formulated product was mixed 
with 100 gallons of water (224 g formulation in 302.8L).  
     Heritage® (50% azoxystrobin, Dow Agrosciences) was applied at a rate of 0.61 kg a.i./ha. 
Heritage® was not applied at the maximum label rate of 1.1 kg/ha used for snow mold control 
because these applications take place shortly before snow cover when the golf season is already 
over. This maximum label rate would, therefore, present an unrealistic exposure scenario. 
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Briefly, 16 oz. of formulated product was mixed with 80 gallons of water (0.454 kg formulation 
in 302.8L). 
     Quicksilver T & O Herbicide® (21.3.0% carfentrazone-ethyl, FMC Corp.) was applied at the 
USEPA maximum label rate of 0.11 kg. a.i./ha. For the Quicksilver application, 6.16 oz. of 
formulated product was mixed with 80 gallons of water and applied at a rate of 2 
gallons/1000ft2 (182.2 ml of formulation in 302.8L applied at 7.6 L/92.9 m2). 
     Mach II 2SC® (22.3% halofenozide, Syngenta) was applied at the USEPA maximum label rate 
of 2.24 kg a.i./ha. For the Mach II application, 7.25 qt. (116 fluid oz.) of formulated product was 
mixed into 80 gallons of water and applied at a rate of 2 gallons/1000ft2 (3.4L of formulation in 
302.8L applied at 7.6 L/92.9 m2).  
     Chlorothalonil and cyfluthrin were applied concurrently in the same tank mix. All other 
pesticides were applied individually. Applications were spaced a minimum of one month apart 
to minimize the possibility of pesticide residues carrying over to the next experiment. Pre-
samples were taken the day before the experiment to ensure that there were no detectable 
residues remaining from the previous application. Insecticide applications (imidacloprid, 
halofenozide) were followed by 0.64 cm of irrigation, as is typical in a grub control treatment. 
2.3 Experimental Site 
     All experiments were performed at the University of Massachusetts Joseph Troll Turfgrass 
Research Center in South Deerfield MA. The latitude and longitude of the site is 42.49°N and 
72.59°WW, respectively, located at 86.9 m in elevation above sea level.A 130 X 30 yard (118.9 x 
27.4 m) plot, consisting of ‘Penncross’ creeping bentgrass, was used for the concurrent 
collection of DFR and dosimetry samples. This plot was maintained as a golf course fairway, 
mowed three times a week at 1.25 cm, and irrigated as needed to prevent drought stress.  
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Additionally, the plot was fertilized with 147 kg lbs N/ha/year in three 49 kg applications, and 
treated with fungicides not used in the current study to control the fungal diseases; dollar spot 
(Sclerotinia homeocarpa), brown patch (Rhizoctonia solani) and pythium blight (Pythium spp.) as 
needed. 
2.4 Weather Data 
     An ET106 weather station (Campbell Scientific, Logan, UT) was used to collect all weather 
data. Pesticide applications and golfer exposure experiments took place when the temperatures 
were seasonal, the wind speed was below 2.24 m/s and no precipitation was forecast for at 
least five days, the two days before and two days after the application, as well as the day of the 
experiment. 
2.5 Collection and Analysis of Dislodgeable Foliar Residues 
     Collections of DFR samples were carried out on the same plot concurrent with the golfer 
exposure study. DFR were determined using the Outdoor Residential Task Force recommended 
California roller device (CA roller, 49).  To construct the CA roller, a 14.5 kg cylinder was 
attached to a handle, allowing it to roll freely across the turf.  A Plexiglass® frame was 
constructed (0.91 x 0.61 meter inside dimensions) so that the contact area of the cloth collector 
would be consistent. Three 2.13 x 3.66 m (7 x 12 feet) sections of the study site (4 samples per 
section) were cordoned off to prevent foot traffic by the study participants. A new 68.6 x 99 cm 
piece of 200 thread count muslin cotton cloth was held in place by the frame, and a new clean 
plastic sheet (6 mm thickness) was placed between the cloth and roller for each sample to 
prevent cross contamination. The device was rolled back and forth across the turf ten times for 
each sample. One 0.91 x 0.61 meter DFR sample (the area inside the frame where the cloth 
contacts the turf) was collected from each section at 0.25, 1, 2, and 5 hours after pesticide 
application. Sections that were sampled had their perimeters marked using turf paint to prevent 
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re-sampling of an area. Following the collection, the cloth was placed in a 500 ml amber bottle 
and frozen (-200 C) until analysis. 
     For analysis, the samples were allowed to equilibrate to room temperature and extracted for 
one hour on a rotary shaker at 200 rpm (Orbital Shaker 3590, Lab-Line, Dubuque, IA) with 350 
ml of the appropriate solvent (Table 2). 
Table 2. Solvents used to extract CA roller cloth samples. 
 
Analyte Extracting solvent Aliquot analyzed 
azoxystrobin Acetonitrile 10 ml 
carfentrazone-ethyl Hexane 200 ml 
chlorothalonil Hexane 1 ml 
cyfluthrin Hexane 10 ml 
2,4-D, MCPP-p 0.1M KOH 100 ml 
halofenozide Methanol 1 ml 
imidacloprid 5:1 Isopropanol:Acetone 1 ml 
 
2.6 GC Analysis of Dislodgeable Foliar Residues 
2.6.1 Azoxystrobin analysis 
     Azoxystrobin CA roller samples were extracted with acetonitrile and analyzed by gas 
chromatography/mass spectrometry (GC/MS). The extract was filtered through Whatmann #1 
filter paper and collected in a 500 ml Erlenmeyer flask. A cleanup was then performed using a 
C18 cartridge (Accubond II 6ml, 1000 mg, Agilent Technologies). Two ml of extract was passed 
through the cartridge and discarded. 10 ml of extract was then passed through the cartridge and 
collected in a 15 ml centrifuge tube. The sample was reduced to 0.5 ml, brought back to 10 ml 
with ethyl acetate and reduced again to 5 ml. Two grams of sodium sulfate was added to the 
sample and the ethyl acetate was removed by pipetting and placed in a clean centrifuge tube. 
The sodium sulfate was then rinsed two more times with 4 ml ethyl acetate each time. These 
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two ethyl acetate rinses were combined with the initial extract and the sample was reduced to 
0.5 ml under nitrogen. 
     Azoxystrobin was analyzed by a GC/MS (6890 GC, 5973 MS, Agilent Technologies, Wilmington 
DE) equipped with a 30m DB-5MS column (0.25mm i.d. x 0.25µm film thickness, Agilent 
Technologies, Wilmington DE). A cyclosplitter injection liner (Restek Corp., Bellafonte PA) was 
used for splitless injection. Helium carrier gas velocity was kept at 30 cm/s. The injector was 
held at 250°C and the detector at 280°C. The oven temperature program was 80°C, ramped to 
300°C at 35°/min. A 2 µl sample was injected onto the column, and the inlet was purged with 
helium at 1.0 minutes. The retention time of azoxystrobin was 10.3 minutes under these 
conditions and azoxystrobin was analyzed in Selected Ion Monitoring (SIM) mode and the ions 
monitored were m/z 344, 372, 388, and 403. 
2.6.2 Carfentrazone-ethyl analysis 
     Carfentrazone-ethyl CA roller samples were extracted with hexane and analyzed by an Agilent 
6890 gas chromatograph/electron capture detector (GC/ECD, 6890 GC, Agilent Technologies, 
Wilmington DE) and confirmed by an Agilent 6890 /5973 GC/MS (see above). A 10 ml aliquot of 
the extracting solution was transferred to a 15 ml centrifuge tube and partitioned with 5 ml of 
15% sodium chloride. The hexane layer was removed and placed in another 15 ml centrifuge 
tube and the sodium chloride solution was extracted 2 more times with 4 ml of hexane each 
time. All hexane extracts were combined and reduced to 1.0 ml for analysis. 
     Carfentrazone-ethyl was analyzed by GC/ECD with a 20m DB-5MS column (0.18mm i.d. x 
0.18µm film thickness, Agilent Technologies, Wilmington DE). A cyclosplitter injection liner 
(Restek Corp., Bellafonte PA) was used for splitless injection. Helium carrier gas velocity was 
kept at 30 cm/s. The injector was held at 250°C and the detector at 310°C. The oven 
temperature program was 100°C, ramped to 300°C at 15°/min and held for 10 minutes. A 2 µl 
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sample was injected onto the column, and the inlet was purged with helium at 1.0 minutes. The 
retention time of carfentrazone-ethyl was 11.7 minutes under these conditions. Samples were 
also confirmed by GC/MS. The column, temperature program and injector temperature were 
the same as for the ECD. The detector was held at 280°C, and operated in SIM mode. The ions 
monitored were m/z 290, 312, 330, 411 for carfentrazone-ethyl analysis. 
2.6.3 Chlororthalonil Analysis 
     Analysis of chlorothalonil CA roller samples were carried out by removing a 1 ml aliquot of 
extracting solvent and filtering through an Acrodisc 13mm, 0.2µm teflon syringe filter (Pall 
Corp., Port Washington, NY) for analysis. 
     Chlorothalonil was analyzed using an Agilent Technologies 6890 GC equipped with a 
nitrogen/phosphorous detector, a 7683 autosampler and a 30m DB-5 column (0.25mm i.d. x 
0.25µm film thickness, Agilent Technologies, Wilmington DE). A cyclosplitter injection liner 
(Restek Corp.), Bellafonte PA) was used for splitless injection. Helium carrier gas velocity was 
kept at 30 cm/s. The injector was held at 250°C and the detector at 300°C. The oven 
temperature program was 80°C for 3 minutes, then ramped to 250°C at 20°/min. A 2 µl sample 
was injected onto the column, and the inlet was purged for 1.0 minutes. 
2.6.4 Cyfluthrin Analysis 
     Analysis of cyfluthrin CA roller samples were carried out by removing a 10 ml aliquot of 
extracting solvent, reducing it to 1 ml under nitrogen, and filtering through an Acrodisc 13mm, 
0.2µm Teflon® syringe filter (Pall Corp., Port Washington, NY) for analysis. 
          Cyfluthrin was analyzed by GC/ECD with a 20m DB-5MS column (0.18mm i.d. x 0.18µm film 
thickness, Agilent Technologies, Wilmington DE). A cyclosplitter injection liner (Restek Corp., 
Bellafonte PA) was used for splitless injection. Helium carrier gas velocity was kept at 30 cm/s. 
The injector was held at 250°C and the detector at 310°C. The oven temperature program was 
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80°C, ramped to 300°C at 15°/min and held for 10 minutes. A 2 µl sample was injected onto the 
column, and the inlet was purged with helium at 1.0 minutes. The retention time of the 4 
cyfluthrin isomers was 13.5-13.8 minutes under these conditions. 
2.6.5 2,4-D and MCPP-p Analysis 
    The phenoxy acid herbicides CA roller samples were analyzed by C18 extraction and boron 
trifluoride (BF3) derivatization using GC/MS (see above) (50). 100 ml of extract was acidified to 
pH 2.0 using 2.0 M HCl. The C18 cartridges (Accubond II, 6ml, 500 mg, Agilent Technologies) were 
conditioned with 6 ml of methanol followed by 6 ml of 1N HCl. A 10 ml aliquot of the acidified 
extract was passed through the cartridge, and air dried for 10 minutes under vacuum. The 
cartridges were washed with 5 ml hexane and eluted with 5 ml ethyl ether. The ether was 
evaporated under N2 at room temperature using an N-Evap (Organomation, Berlin, MA), and the 
sample reconstituted with 6 ml of methanol. A 3 ml aliquot of the methanol extract was placed 
in a glass centrifuge tube and 1.5 ml of 0.5N sodium hydroxide/methanol was added and 
vortexed. The sample was heated to 100°C in an oil bath for 5 minutes and allowed to cool to 
room temperature. A 1 ml volume of BF3 solution (14% in MeOH, Sigma Aldrich, St. Louis MO) 
was added and the sample vortexed and heated to 100° C for 20 minutes.  
     A second cleanup was carried out on the derivatized samples. While the samples were 
cooling to room temperature, C18 cartridges (Accubond, 6 ml x 1000 mg, Agilent Technologies) 
were conditioned with 6 ml ethyl acetate and air dried under vacuum for 15 minutes. This 
process was followed by 10 ml methanol, and 10 ml 0.1M phosphoric acid. A 60 ml volume of 
0.1M phosphoric acid was added to the sample and it was run through the cartridge under 
vacuum in a dropwise fashion. The samples were air dried under vacuum for 30 minutes. The 
analytes were eluted with 10 ml ethyl acetate and adjusted to the appropriate volume for 
analysis.     
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Samples of 2,4-D and MCPP were analyzed by a GC/MS  (see above) equipped with a 30m DB-
5MS column (0.25mm i.d. x 0.25µm film thickness, Agilent Technologies, Wilmington DE). A 
cyclosplitter injection liner (Restek Corp., Bellafonte PA) was used for splitless injection. Helium 
carrier gas velocity was kept at 30 cm/s. The injector was held at 250°C and the detector at 
280°C. The oven temperature program was 80°C, ramped to 220 °C at 15°C/min then to 300 at 
30°C/min. A 2 µl sample were injected onto the column, and the inlet was purged with helium 
at 1.0 minutes. The retention time of azoxystrobin was 10.3 minutes under these conditions and 
azoxystrobin was analyzed in SIM mode and the ions monitored were m/z 344, 372, 388, and 
403. 
2.7 LC/MS Analysis 
 
2.7.1 Halofenozide Analysis 
 
     Analysis of halofenozide CA roller samples were carried out by removing a 1 ml aliquot of the 
extracting solvent. This aliquot was reduced to dryness under N2, reconstituted in 50:50 
acetontrile:water, filtered through a Acrodisc 13mm, 0.2µm nylon syringe filter (Pall Corp.) and 
analyzed by liquid chromatography/mass spectrometry (LC/MS). 
     Halofenozide was analyzed by LC/MS/MS (Alliance LC and Acquity MS/MS, Waters Corp. 
Milford MA) using a 100 mm Atlantis T3 column (2.1 mm i.d., 3.0 µm particle size, Waters Corp. 
Milford MA). The analysis used following gradient (Table 3) using 0.1% formic acid and 
acetonitrile at a flow rate of 0.25 ml/min. Injection volume was 20µl. Electrospray ionization was 
operated in negative mode with the collision gas (argon) set to 0.10 ml/min. The cone voltage 
was set to 27 and the transitions monitored were 329.14 to 154.8, 175.8, and 271.8. Retention 
times were 14.6 and 15.1 minutes for halofenozide isomers. 
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Table 3. LC gradient for halofenozide.  
 
Time (minutes) 0.1% formic acid Acetonitrile  
0 80 20 
1 60 40 
5 60 40 
15 40 60 
16.5 40 60 
17 80 20 
24 80 20 
 
2.7.2 Imidacloprid Analysis 
Analyses of imidacloprid CA roller samples were carried out by removing a 1 ml aliquot of the 
extracting solvent. (51). This aliquot was reduced to dryness under N2, reconstituted in 50:50 
acetontrile:water, filtered through a Acrodisc 13mm, 0.2µm nylon syringe filter (Pall Corp.) and 
analyzed by liquid chromatography/mass spectrometry (LC/MS). 
       Imidacloprid was analyzed by LC/MS (Agilent 1100 LC, 1100MS) using a 150 mm Zorbax C18 
Stable Bond HPLC column (3.0 mm i.d., 5.0 µm particle size, Agilent Technologies). The isocratic 
chromatographic analysis used 65% of solution A (95:5 50 mM ammonium formate:acetonitrile) 
and 35% of solution B (95:5 acetonitrile:deionized water) at a flow rate of 0.30 ml/min. Injection 
volume was 40µl. Electrospray ionization was operated in positive mode with the fragmentor 
set to 80 volts and drying gas (nitrogen) flow at 10 L/min at 325°C. The nebulizer was set to 
0.345 MPa, and the VCap (pos) was set to 3000 volts. Ions monitored were m/z 209, 256, 278, 
and 280. Imidacloprid was quantitated on m/z 256. 
 
2.8 Golfer Exposure Scenario 
 
Pesticides were applied to a rectangular bentgrass plot (130 x 30 yards, 118.9 x 27.4 m) 
maintained as a golf course fairway. Exposure to volunteers simulating the play of a round of 
golf was determined by a dosimetry and biomonitoring.  Concurrent with this study, DFR 
samples were collected from the same plot. Exposure experiments utilized two groups 
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(dosimetry or biomonitoring) with four volunteers in each: members of the dosimetry group 
wore whole body dosimetry suits, baseball caps with vail covering the back of the neck, cotton 
gloves and personal air samplers; and members of the biomonitoring group wore dosimeter 
suits cut to mimic standard golf attire (shorts and a short sleeve shirt) and baseball caps without 
a vail. Each group simulated the play of an 18-hole round of golf over a period of four hours. The 
round of golf was standardized in an attempt to ensure consistent behaviors amongst the 
different volunteers. The standardized protocol was based on all volunteers playing bogey golf 
(par plus one stroke per hole). Each player hit the ball 90 times, additionally taking 90 practice 
swings, while walking the 5943.6 m (6500 yard) layout of a local course. Golf clubs were rotated 
in an appropriate manner, balls were teed up on tee shots, divots were replaced, and the clubs 
were wiped clean between shots using a golf towel. Each simulated round of golf commenced 
either one-hour after application (chlorothalonil, 2,4-D, MCPP-p, dicamba, azoxystrobin, 
carfentrazone-ethyl) or one hour after the end of post-application irrigation (imidacloprid, 
halofenozide). 
2.8.1 Volunteers 
     Volunteers were recruited by word of mouth from the Department of Veterinary and Animal 
Science.  A protocol describing the project and assuring the rights of the volunteers was 
approved by the Human Subjects Review Committee, UMASS-Amherst, OGCA# 107-0889. The 
informed consent form used in the project was provided with this documentation. All this 
information was reviewed with the volunteers at an orientation session. 
2.9 Whole Body Dosimeters 
     Volunteers in the dosimetry group wore baseball caps, and white, 100% cotton, long johns 
(Indera Mills Co., Yadkinville, NC) covering the entire body except for the feet, hands, and head. 
To determine exposure in these regions, they also wore two layers of white cotton lisle 
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inspection gloves (Wells Lamont, Niles, Illinois), white 100% cotton socks (The Railroad Sock, 
Kansas City, MO), and veils (19.1 x 35.6 cm, 200 thread count white cotton muslin) attached to 
the back of their caps. These dosimeters served as the collection media for pesticide residues 
from treated turfgrass (11, 26). Volunteers changed their double-layer cotton gloves midway 
through the 4-hour exposure scenario and the two sets of gloves were combined for extraction. 
The socks were cut into lower and upper sections and analyzed separately. The dosimetry suit 
was sectioned into lower arms, upper arms, torso, upper legs, and lower legs and these 
segments were analyzed separately. 
     The suit sections were placed in amber bottles after sectioning and extracted with the listed 
volume (Table 4) of the appropriate solvent for each analyte (Table 3., CA roller above) by 
shaking for 2 hours on a rotary shaker.   
Table 4. Solvent volumes used to extract individual sections of the dosimetry sections. 
 
Dosimetry Suit Sections Amber Jar Size (ml) Solvent Added (ml) 
LOWER ARM 500  400  
UPPER ARM 500  400  
GLOVE 500  400  
LOWER LEG 500  400  
LOWER SOCK 500  250  
UPPER SOCK 500  250  
PANT 1000  850  
TORSO 1000  800  
VEIL 250  100  
 
2.10 GC analysis of Whole Body Dosimeters 
 
 
2.10.1 Azoxystrobin 
 
     Azoxystrobin was extracted from the dosimeter segments as was done for the CA rollers 
above except that the final volume of ethyl acetate was 15 ml for gloves, upper socks, and lower 
socks. 
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    Instrument conditions were the same as that used for the analysis of CA roller samples for 
azoxystrobin. 
2.10.2 Carfentrazone-ethyl 
 
     One-half of the extracted volume from the carfentrazone-ethyl dosimeter samples was 
removed and partitioned with 15% NaCl at 2:1 ratio for 1 min using a 500 ml separatory funnels. 
The organic layer (hexane) was filtered through Whatman #1 filter paper containing 25g 
anhydrous sodium sulfate into a 500 ml round bottomed flask. 
The water portion was returned to the separatory funnel and the partitioning repeated with an 
additional 50 ml aliquot of hexane. The hexane portions were combined and the sodium sulfate 
(Na2SO4) was rinsed with 25 ml hexane and added to the combined extracts. The hexane extract 
was reduced under vacuum and adjusted to a final volume to 10 ml and filtered through an 
Acrodisc 13mm, 0.45µm Teflon® syringe filter (Pall Corp.) for analysis by GC/ECD. 
     Instrument conditions were the same as that used for the analysis of CA roller samples for 
carfentrazone-ethyl. 
2.10.3 Chlorothalonil 
     A 1 ml aliquot of the extracting solvent was removed from the sample jar of the 
chlorothalonil dosimetry samples and filtered through an Acrodisc 13mm, 0.45µm teflon syringe 
filter (Pall Corp.) for analysis by GC/NPD.  
     Instrument conditions were the same as those used for the analysis of CA roller sample for 
chlorothalonil. 
2.10.4 Cyfluthrin 
     A 10 ml aliquot of the extracting solvent was removed from the sample jar of the cyfluthrin 
dosimetry samples, reduced to 2 ml and filtered through an Acrodisc 13mm, 0.45µm Teflon® 
syringe filter (Pall Corp.) for analysis by GC/ECD.  
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     Instrument conditions were the same as those used for the analysis of CA roller sample for 
cyfluthrin. 
2.10.5 2,4-D and MCPP-p 
     An aliquot of the extracting solvent used for the 2,4-D and MCPP-p dosimetry samples (Table 
2) was acidified to pH 2.0. The extraction followed the method described above for the 
extraction of 2,4-D and MCPP-p from CR sample (pg. 23), except that the entire aliquot of 
extract from the different segments (Table 5) was put through the first clean-up step, and the 
final volume of the extract was 2.0 ml.  
Table 5. Volume of extracting solvent and aliquot of extract removed for clean-up. 
Dosimetry Suit Sections 0.1M KOH Added (ml) 0.1M KOH Aliquot (ml) 
LOWER ARM 400  250  
UPPER ARM 400  250  
GLOVE 400  250  
LOWER LEG 400  250  
LOWER SOCK 250  125  
UPPER SOCK 250  125  
PANT 850  250  
TORSO 800  250 
VEIL 100  50  
      
     Instrument conditions were the same as those used for the analysis of CA roller samples for 
2,4-D and MCPP-p. 
2.11 LC/MS Analysis 
2.11.1 Halofenozide 
   The extraction procedure followed that used for the halofenozide CA roller samples described 
above.  
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   Instrument conditions were the same as those used for the analysis of CA roller sample for 
halofenozide. 
2.11.2 Imidacloprid 
   The extraction procedure followed that used for the imidacloprid CA roller samples described 
above.  
    Instrument conditions were the same as those used for the analysis of CA roller sample for 
imidacloprid. 
2.12 Personal Air Samplers 
     All volunteers of the dosimetry group wore personal air samplers consisting of an Airchek® 
52 sample pump (SKC Inc., Eight Four, PA) connected to XAD-2 OVS sampling tubes (SKC Inc.) 
consisting of a quartz filter, followed by 2 sections of XAD-2 resin separated by a frit. The first 
section contained 140 mg of resin and the second 270 mg in order to collect volatile samples 
and to determine possible breakthrough. The tubes were attached to the front collar of each 
volunteer near the breathing zone (11, 52). These sampling tubes trap three types of pesticide 
residues: those sorbed onto particulates (e.g., dust) and those found in aerosols are trapped by 
a quartz filter, and pesticide vapors, which are trapped on XAD-2 resin in the tubes.  Air samples 
were collected at 2.0 L/min. To estimate total airborne dose of the pesticide, the residues found 
in the sampling tubes were multiplied by 10.5 to arrive at the dose correlated with a moderate 
breathing rate of 21 L/min.  
     The front section of XAD-2 resin and quartz filter were analyzed together. The polyurethane 
foam plug and second section of resin were analyzed separately to determine if there was any 
breakthrough of the pesticide. 
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2.13 GC/MS Analysis of Personal Air Samplers 
2.13.1 Azoxystrobin 
     Azoxystrobin was extracted from the personal air sampler tube by desorbing the sections in 
2.0 ml acetonitrile and sonicating the centrifuge tube in a water bath (40kHz, Bransonic 220, 
Branson Ultrasonics, Danbury, CT) for 30 minutes. A 1 ml aliquot was removed, evaporated 
under nitrogen, and reconstituted in 0.5 ml 50:50 acetonitrile:water. The extract was filtered 
through an Acrodisc 13mm, 0.45 µm Teflon® syringe filter (Pall Corp.) for analysis by GC/MS.  
     Instrument conditions were the same as those used for the analysis of CA roller samples for 
azoxystrobin. 
2.13.2 Carfentrazone-ethyl 
     Carfentrazone-ethyl was extracted from the personal air sampler tube by desorbing the 
sections in 2.0 ml acetone on a tabletop shaker. A 1 ml aliquot was removed, evaporated under 
nitrogen, and reconstituted in 0.5 ml acetone. The extract was filtered through an Acrodisc 
13mm, 0.45µm Teflon® syringe filter (Pall Corp) for analysis by GC/MS.  
     Instrument conditions were the same as those used for the analysis of CA roller samples for 
carfentrazone-ethyl. 
2.13.3 Chlorothalonil 
     The personal air sample tubes were extracted for chlorothalonil by desorbing the sections in 
2 ml toluene for 30 minutes on a tabletop shaker (53). The toluene extract was evaporated just 
to dryness under nitrogen and reconstituted in 0.5 ml hexane.  
     Instrument conditions were the same as those used for the analysis of CA roller samples for 
chlorothalonil. 
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2.13.4 Cyfluthrin 
     The personal air sample tubes were extracted for cyfluthrin by desorbing the sections in 2 ml 
toluene containing 2 µg/ml triphenyl phosphate (TPP) for 30 minutes on a tabletop shaker). The 
toluene extract was evaporated just to dryness under nitrogen and reconstituted in 0.5 ml 
hexane.  
     Instrument conditions were the same as those used for the analysis of CA roller samples for 
cyfluthrin. 
2.13.5 2,4-D and MCPP-p 
     Phenoxy herbicides 2,4-D and MCPP-p, were extracted from the personal air sampler tubes 
based on NIOSH Method 5602 (54). Diazomethane was produced using a Wheaton millimolar 
diazomethane generator (281135, Wheaton Scientific, Millville, NJ). The sections were extracted 
by rotating with 2 ml of the resulting diazomethane derivatizing reagent (90:10 methyl t-butyl 
ether:methanol with diazomethane) on a tabletop shaker at 10 rpm for 1 hour. 10 mg of silicic 
acid were added to each sample, vortexed, and allowed to stand one hour. In a departure from 
NIOSH 5602, 1 ml of extract was evaporated just to dryness under nitrogen at room 
temperature and reconstituted in 1 ml hexane.  
     Instrument conditions were the same as those used for the analysis of CA roller samples for 
2,4-D, and MCPP-p. 
2.14 LC/MS Analysis of Personal Air Samplers 
 
2.14.1 Halofenozide 
     Halofenozide was extracted from air samplers by sonicating with 2 ml methanol for 30 min.  A 
1 ml aliquot was removed, reduced to dryness under nitrogen, reconstituted in 50:50 
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acetonitrile:water, and filtered through an Acrodisc 13mm, 0.20 µm nylon syringe filter (Pall 
Corp.) for analysis by LC/MS.  
     Instrument conditions were the same as those used for the analysis of CA roller samples for 
halofenozide. 
2.14.2 Imidacloprid 
     Imidacloprid residues from personal air samplers were extracted following a method 
provided by Bayer (55). Air samplers were extracted by sonicating with 2 ml methanol for 30 
min.  A 1 ml aliquot was removed, reduced to dryness under nitrogen, reconstituted in 50:50 
acetonitrile:water, and filtered through an Acrodisc 13mm, 0.20µm nylon syringe filter (Pall 
Corp.) for analysis by LC/MS.  
     Instrument conditions were the same as those used for the analysis of CA roller samples for 
imidacloprid. 
2.15 Biomonitoring Analysis 
     All biomonitoring samples were analyzed in triplicate. 
 
2.15.1 Azoxystrobin 
    Azoxystrobin samples were not analyzed for urinary metabolites due to the unavailability of 
reliable pharmacokinetic data and analytical standards for these metabolites. There was also no 
single abundant urinary metabolite. 
2.15.2 Carfentrazone-ethyl 
     Residues of carfentrazone chloropropionic acid were analyzed in urine using solid phase 
extraction and LC/MS/MS (56). Briefly, samples were shaken vigorously by hand for 30 seconds, 
and a 2 ml aliquot was transferred to a clear 8 ml vial. 4 ml of 0.1% formic acid was added to the 
sample. C18 cartridge (Accubond II 3cc, 60 mg, Agilent Technologies, Wilmington DE) were 
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conditioned with 6 ml methanol, followed by 6 ml deionized water. The samples were loaded 
onto the cartridge, and air dried for 3 min under vacuum. The samples were eluted with 1 ml 
methanol, reduced to dryness under nitrogen, and reconstituted in 50:50 acetonitrile:water. The 
samples were filtered through an Acrodisc 13mm, 0.20µm nylon syringe filters (Pall Corp.) for 
analysis by LC/MS/MS.   
Carfentrazone propionic acid was analyzed by LC/MS/MS (Alliance LC and Acquity MS/MS, 
Waters Corp. Milford MA) using a 100 mm Atlantis T3 column (2.1 mm i.d., 3.0 µm particle size, 
Waters Corp. Milford MA). The analysis used following gradient (Table 6) with 0.1% formic acid 
and methanol with 0.1% formic acid at a flow rate of 0.20 ml/min. 
 Table 6. LC gradient for carfentrazone propionic acid analysis. 
 
Time (minutes) 0.1% formic acid Methanol/0.1%formic acid  
0 95 5 
1 95 5 
5 5 95 
11.5 5 95 
11.6 95 5 
17.6 95 5 
 
      Injection volume was 20 µl. Electrospray ionization was operated in negative mode with the 
collision gas (argon) set to 0.15 ml/min. The cone voltage was set to 19 and the transitions 
monitored were 381.85 to 209.0, 262.2, and 346.0. Retention times was 10.4 minutes. 
2.15.3 Chlorothalonil 
         Urine samples were analyzed for parent chlorothalonil following a method by Aprea et al. 
(53). Samples were heated to 40° C for 10 minutes in a water bath. The samples were inverted 
three times, and 10 ml were transferred to a 50 ml centrifuge tube. 2 ml acetone and 10 ml 
hexane were added to the sample followed by vortexing for 30 sec. Samples were then 
centrifuged for 10 minutes at 2500 rpm and 20°C. The organic layer was transferred to a clean 
35 
 
15 ml centrifuge tube. The urine sample was re-extracted with 5 ml hexane and the organic 
phase transferred to the 15 ml centrifuge tube. 0.5 grams sodium sulfate was added to each 
tube and vortexed for 5 seconds. The sample was then transferred to a new 15 ml centrifuge 
tube. The sodium sulfate was rinsed 2 times with 2 ml hexane and this was added to the 
centrifuge tube. The samples were evaporated to dryness under nitrogen and reconstituted in 
0.5 ml hexane, and filtered through an Acrodisc 13mm, 0.45µm Teflon® syringe filter (Pall Corp.) 
for analysis by GC/MS.  
   Chlorothalonil biomonitoring samples were analyzed by a GC/MS (6890 GC, 5973 MS, Agilent 
Technologies, Wilmington, DE) equipped with a 30 m DB-5MS column (0.25mm i.d. x 0.25µm 
film thickness, Agilent Technologies, Wilmington, DE). A cyclosplitter injection liner (Restek 
Corp., Bellafonte, PA) was used for splitless injection. Helium carrier gas velocity was kept at 30 
cm/s. The injector was held at 250°C and the detector at 280°C. The oven temperature program 
was 100°C, ramped to 300°C at 15°/min. A 2 µl sample was injected onto the column and the 
inlet was purged with helium at 1.0 minutes. The retention time of chlorothalonil was 9.2 
minutes under these conditions. Chlorothalonil was analyzed in SIM mode and the ions 
monitored were m/z 264,266, and 268. 
2.15.4 Cyfluthrin 
     Urine samples were analyzed for the three most abundant cyfluthrin metabolites: methyl 4-
fluoro-3-phenoxybenzoate (FPBA); 4-fluoro-3-(4-hydroxyphenoxy)-benzoic acid (FPBA-OH); and 
methyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclo-propanecarboxylate (DBCA), using a modification 
of the procedure descried by Schettgen et al (57). A 5-ml aliquot of urine was placed in 20 ml 
screw top centrifuge tubes and amended with 10 µl of 2-PBA internal standard solution. 
Conjugates were acid hydrolyzed to free carboxylic acids by adding 1 ml conc. HCl and 
incubating 1 hr at 90oC. The samples were then alkalized to pH 13-14 with 12 M sodium 
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hydroxide, treated with 2 ml hexane and shaken for 5 min. The organic layer was discarded 
following centrifugation at 500 g for 10 min and the aqueous layer reacidified to pH 1-2 with 
conc. HCl. The acid metabolites were extracted into 2 ml chlorobutane by shaking for 5 min. The 
organic layer was collected following centrifugation, and the procedure was repeated twice. The 
combined chlorobutane extract was dried by adding approximately 0.5 g anhydrous sodium 
sulfate and vortexing briefly. The dried extract was quantitatively transferred to a new tube with 
chlorobutane and reduced to 0.5 ml under N2.  The metabolites were derivatized for 1 hr at 60oC 
with 100 µl of N-methyl-N-[tert-butyldimethylsilyl] triflouroacetamide for GC/MS analysis.   
     Cyfluthrin biomonitoring samples were analyzed by a GC/MS (6890 GC, 5973 MS, Agilent 
Technologies, Wilmington DE) equipped with a 30m DB-5MS column (0.25mm i.d. x 0.25µm film 
thickness, Agilent Technologies, Wilmington DE). A cyclosplitter injection liner (Restek Corp., 
Bellafonte PA) was used for splitless injection. Helium carrier gas velocity was kept at 30 cm/s. 
The injector was held at 250°C and the detector at 280°C. The oven temperature program was 
90°C (hold 2 minutes), then ramped to 300°C at 10°/min. A 2 µl sample was injected onto the 
column, and the inlet was purged with helium at 1.0 minutes. The metabolites were analyzed in 
SIM mode and the ions monitored were m/z 265,267, and 128 for DBCA, 289,245 and 215 for 
FPBA, 377,476,419, and 181 for FPBA-OH, and 271 for 2-PBA (internal standard). 
2.15.5 2,4-D and MCPP-p 
     After comparing methods involving hydrolysis of the urine prior to extraction with methods 
using no hydrolysis, it was determined that avoiding hydrolysis resulted in better spike 
recoveries and greater recoveries of the compounds from actual field samples.  
     Residues of 2,4-D and MCPP were analyzed in urine using solid phase extraction and 
LC/MS/MS (58-60). Briefly, samples were shaken vigorously by hand for 30 seconds, and a 2 ml 
aliquot was transferred to a clear 8 ml vial. A 4 ml volume of 0.1% formic acid was added to the 
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sample. Oasis HLB cartridges (3cc x 60 mg, Waters Corporation, Milford MA) were conditioned 
with 6 ml methanol, followed by 6 ml deionized water. The samples were loaded onto the 
cartridge, and air dried for 3 minutes under vacuum. The samples were eluted with 1 ml 
methanol, which was reduced to 0.5 ml for analysis. The samples were filtered through an 
Acrodisc 13 mm, 0.20 µm nylon syringe filters (Pall Corp.) for analysis by LC/MS/MS.  Matrix 
matched standards were used for quantitation, meaning the standards were made in a solution 
of urine extract. 
     Ohenoxy herbicides 2,4-D and MCPP were analyzed by LC/MS/MS (Alliance LC and Acquity 
MS/MS, Waters Corp. Milford MA) using a 50 mm Inertsil ODS-4 Stable Bond column (2.1 mm 
i.d., 3.0 µm particle size, Phenomenex, Torrance, CA). The analysis used following gradient:  A: 
0.1% formic acid B: acetonitrile with 0.1% formic acid at a flow rate of 0.20 ml/min (Table 7). 
Table 7. LC gradient for 2,4-D and MCPP.  
 
Time (minutes) 0.1% Formic acid Acetonitrile/0.1% Formic acid  
0 90 10 
4 10 90 
9 10 90 
9.1 90 10 
14.1 90 10 
 
   Injection volume was 10 µl. Electrospray ionization was operated in negative mode with the 
collision gas (argon) set to 0.15 ml/min (2,4-D) or 0.10 ml/min (MCPP). The cone voltage for 2,4-
D analysis was set to 27 and the transitions monitored were 218.99 to 159.227, 160.853, and 
174.903. The cone voltage was set to 15 for MCPP analysis and the transitions monitored were 
213.124 to 140.746, 175.679, and 180.189. Retention times were 7.4 minutes for 2,4-D, and 7.7 
min for MCPP. 
 
2.15.6 Halofenozide 
Halofenozide samples were not analyzed for urinary metabolites due to the unavailability of 
pharmacokinetic data and analytical standards. 
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2.15.7 Imidacloprid 
     Urine samples were analyzed for imidacloprid and its 6-chloronicotinic acid (6-CNA) 
metabolite by solid phase extraction and LC/MS/MS analysis (58,59) using isotope dilution mass 
spectrometry. Samples were shaken vigorously by hand for 30 sec and a 1 ml aliquot of urine 
was placed into an 8.0 ml vial. A 2 ml volume of 0.1% formic acid in deionized water was added 
to the sample and vortexed for 30 sec. The sample was allowed to sit at room temperature for 1 
hour to hydrolyze 6-CNA-glycine to 6-CNA. An Oasis HLB cartridge (3 ml, 60 mg, Waters Corp., 
Milford MA) was conditioned using 3 ml methanol, followed with 3 ml water. Samples were 
then passed through the cartridges and air dried for 3 min under vacuum. The cartridges were 
eluted with 1 ml methanol. Eluents were reduced to dryness under nitrogen and reconstituted 
in 0.5 ml internal standard solution (0.05 µg/ml 13C, d3 imidacloprid) in methanol. Samples were 
diluted with 0.5 ml water and filtered through an Acrodisc 13mm, 0.20µm nylon syringe filters 
(Pall Corp.) for analysis by LC/MS/MS. 
     Imidacloprid and 6-CNA were analyzed by LC/MS/MS (Alliance LC and Acquity MS/MS, Waters 
Corp. Milford MA) using a 100 mm Kinetix C18 core shell column (2.1 mm i.d., 2.6 µm particle 
size, Phenomenex, Torrance, CA). The analysis used following gradient with 0.1% formic acid and 
acetonitrile with 0.1% formic acid at a flow rate of 0.20 ml/min (Table 8). 
Table 8. LC gradient for imidacloprid and 6-Chloronicotinic acid.  
 
 
      Injection volume was 20 µl. Electrospray ionization was operated in negative mode with the 
collision gas (argon) set to 0.2 ml/min. The cone voltage for imidacloprid analysis was set to 31 
Time (minutes) 0.1% Formic acid Acetonitrile/0.1% Formic acid  
0 5 95 
3 95 5 
9 95 5 
9.1 5 95 
14.1 5 95 
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and the transitions monitored were 256.09 to 127.74, 174.82, and 209.02. The cone voltage was 
set to 33 for 6-CNA analysis and the transitions monitored were 157.97 to 111.9, and 122.0. The 
cone voltage was set to 29 for 13C,d3 imidacloprid analysis and the transitions monitored were 
260.97 to 180.0, and 213.6. Retention times were 5.46 min for imidacloprid and the deuterated 
internal standard, and 5.39 minutes for 6-CNA. 
2.16 Risk Assessment 
     The risk to golfers was assessed using the USEPA Hazard Quotient (HQ) (61) and Margin of 
Exposure (MOE) calculations for both the dosimetry and biomonitoring data. To calculate the 
Hazard Quotient, the estimated absorbed dose (AD, µg/kg/d) was divided by the USEPA acute 
reference dose (RfD, µg/kg/d) (Eqn. 3). The RfD is calculated using the No Observable Adverse 
Effect Level (NOAEL), the highest dose in a toxicological study that produced no deleterious 
effects on the test animals, or sometime the Lowest Observable Adverse Effect Level (LOAEL). 
This NOAEL is then divided by uncertainty factors, typically 10x for interspecies differences and 
10x for intraspecies differences. There is frequently a Food Quality Protection Act Safety Factor 
(FQPA SF) of 3, for the protection of infants and children. These numbers can be raised if the 
USEPA deems the data available inadequate. HQ values greater than 1 indicate that there is 
potential for adverse effects to occur. 
Eqn. 3                                                         𝐻𝑄 =
𝐴𝐷
𝑅𝑓𝐷
 
 
     The RfD includes safety factors to protect vulnerable populations including children and 
women of childbearing age. Dermal RfD were used when available. Otherwise, oral RfD were 
used due to their availability and the fact that the pharmacokinetics more closely resemble 
those following dermal exposure than the alternative, inhalation exposure. Acute reference 
doses were chosen because golfers would not be repeatedly exposed to pesticides immediately 
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after application over many years. Additionally, there are legal restrictions on the timing and 
number of times individual pesticides can be applied, further limiting the likelihood of repeated, 
post-application exposures. 
    Margin of exposure is an alternative way to look at risk assessment. Simply put, the margin of 
exposure is the NOAEL, (µg/kg/d) divided by the AD (Eqn. 4). The greater the MOE, the less likely 
adverse effects will occur due to an exposure. 
Eqn. 4                                                               𝑀𝑂𝐸 =
𝑁𝑂𝐴𝐸𝐿
𝐴𝐷
 
 
     The MOE does not incorporate any safety factors. These factors are incorporated when 
developing a Level of Concern (LOC). The incorporation of the safety factors into the RfD for 
inter (10x)- and intraspecies (10x) differences translates to a LOC for the MOE at 100.  
Incorporation of the FQPA SF (3x) raises the LOC to 300. Typically, concerns about an exposure 
arise when the MOE is less than 1000.  
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CHAPTER 3 
 RESULTS 
3.1 Dislodgeable Foliar Residues 
 
3.1.1 DFR Method Performance 
     Each extraction included a daily matrix blank (white cotton muslin) and fortified matrix spike 
(white cotton muslin with analytical standard added).  A 1.0 ml aliquot of an analytical standard 
solution was added to the matrix in an amber glass bottle.  The sample was left in the hood 
uncapped for 1 hour to allow the solvent to evaporate. The extraction then proceeded as 
with the samples.  
1) Azoxystrobin DFR 
    Spike recoveries for the azoxystrobin DFR matrix averaged 102.2% (± 7.25%, N=8). 
2) Carfentrazone-ethyl DFR 
    Carfentrazone-ethyl recoveries from DFR matrix averaged 94.4% (± 11.3%, N =3).  
3) Chlorothalonil DFR 
     Chlorothalonil recoveries from DFR matrix averaged 96.3% (± 14.9%, N =3).  
4) Cyfluthrin DFR 
    Cyfluthrin recoveries from DFR matrix averaged 88.2% (± 15.6%, N =3).  
5) 2,4-D DFR 
   2,4-D recoveries from DFR matrix averaged 102.5% (± 6.4%, N =3).  
6) Halofenozide DFR 
  Spike recoveries for the halofenozide DFR matrix averaged 89.0% (± 9.8, N=8).  
7) Imidacloprid DFR 
   Imidacloprid recoveries from DFR matrix averaged 93.7% (± 10.4%, N =3).  
8) MCPP-p DFR 
     MCPP-p recoveries from DFR matrix averaged 92.4% (± 7.2%, N =3).  
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3.1.2 Azoxystrobin DFR 
     For azoxystrobin and all following compounds (except MCPP-p), a sample was taken 0.25-
hours post-application or post-irrigation, depending on whether post-application irrigation was 
used. Azoxystrobin residues declined rapidly in the first 2 hours following application, then 
exhibited a slower decline over the next three hours (Fig. 2).  Azoxystrobin DFR declined from 
0.60 μg/cm2 (± 0.04 S.E) at 0.25 hours to 0.34 μg/cm2 (± 0.03) at  hour 1 (a 43% reduction), and 
then to 0.02 μg/cm2 (± 0.0008) at hour 5, a 30-fold reduction from hour 0.25 to hour 5. 
Azoxystrobin DFR declined from 0.34 μg/cm2 (± 0.03) at hour 1 to 0.07 μg/cm2 at hour 2 (4.9-
fold reduction), and then to 0.02 μg/cm2 (± 0.005) in the next three hours for a 17-fold 
reduction in available residues over hours 1-5, the time the volunteers played their round of 
simulated golf. This dissipation pattern indicates that it is appropriate for DFRs to be averaged 
over a four-hour period, our standardized playing time for an 18-hole round of golf (hours 1-5), 
for use in exposure estimates (1). Using this approach, a mean DFR of 0.146 (±0.015) μg 
azoxystrobin/cm2 was calculated for the time course of the experiment (hours 1-5) following 
application at a rate of 0.65 kg a.i./ha (0.2 oz. a.i./1000ft2).  
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Figure 2: Availability of azoxystrobin dislodgeable foliar residues (DFR) over the first five hours 
following application. 
 
3.1.3 Carfentrazone-ethyl DFR 
     Dissipation of DFR of carfentrazone-ethyl followed a similar pattern (Fig. 3). DFR of 
carfentrazone-ethyl declined from 0.00082 μg/cm2 (± 0.000011) at 0.25-hours post-application 
to 0.00052 μg/cm2 (± 0.000016) at hour 1 (a 37% reduction), and then to 0.00026μg/cm2 (± 
0.0008) at hour 5, a 68.3% reduction from hour 0.25 to hour 5. DFR of carfentrazone-ethyl 
declined from 0.00052 μg/cm2 (± 0.000016) at hour 1 to 0.0004 μg/cm2 (± 0.000098) at hour 2, 
resulting in a 25% reduction of available residues over the first hour. Available residues then 
decreased to 0.00026 μg/cm2 (± 0.0008) at hour 5, for a reduction of 50% over the time course 
of the experiment. A mean DFR was calculated as 0.0004 (±0.000014) μg carfentrazone-
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ethyl/cm2 for the time course of the experiment (hours 1-5) following application at a rate of 
0.00011 kg a.i./ha (0.035 oz. a.i./1000ft2). 
 
 
Figure 3: Availability of carfentrazone-ethyl dislodgeable foliar residues (DFR) over the first five 
hours following application. 
 
3.1.4 Chlorothalonil DFR 
     Dissipation of DFR of chlorothalonil likewise followed a similar pattern (Fig. 4). DFR of 
chlorothalonil declined from 5.83 μg/cm2 (± 1.86) at 0.25 hours to 2.89 μg/cm2 (± 1.66) at hour 1 
(a 50% reduction), but this decline was not statistically significant. Residues then declined to 
0.35 μg/cm2 (± 0.06) at hour 5, resulting in a 16.7-fold reduction in available residues from hours 
0.25 to 5. DFR of chlorothalonil declined from 2.89 μg/cm2 (± 1.66) at hour 1 to 1.2 μg/cm2 (± 
1.86) at hour 2, a 2.4-fold reduction, but this decline was not statistically significant. Residues 
further declined to 0.35 μg/cm2 (± 0.06) at hour 5, resulting in an 8.3-fold reduction in available 
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residues over the time course of the experiment (hours 1-5). A mean DFR was calculated as 1.48 
(±1.29) μg chlorothalonil/cm2 for the time course of the experiment (hours 1-5) following 
application at rate of 12.7 kg/ha (1323 oz. a.i./1000ft2). 
 
 
Figure 4: Availability of chlorothalonil dislodgeable foliar residues (DFR) over the first five hours 
following application. 
 
3.1.5 Cyfluthrin DFR With and Without Irrigation 
     Cyfluthrin was applied with post-application irrigation in a previous study using the same 
protocol (11). We subsequently applied cyfluthrin without irrigation. Each experiment was 
replicated three times. Dissipation of cyfluthrin DFR followed a similar pattern to previous 
compounds (Fig. 5). Without irrigation, DFR of cyfluthrin declined from 0.038 μg/cm2 (± 0.026) 
at hour 1 to 0.016 μg/cm2 (± 0.0018) at hour 2, a 58% reduction, then to 0.0046μg/cm2 (± 
0.0008) at hour 5, resulting in an 8.3-fold reduction from hour 1 to 5. A mean DFR was 
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calculated as 0.020 (±0.014) μg cyfluthrin/cm2 for the time course of the experiment (hours 1-5) 
following application at rate of 0.02 kg a.i./ha (12.3 oz. a.i./1000ft2). 
     With irrigation, DFR of cyfluthrin declined from 0.0023 μg/cm2 (± 0.0011) at hour 1 post-
irrigation to 0.0007 μg/cm2 (± 0.00017) at hour 2 (a 70% reduction), and then to 0.0005 μg/cm2 
(± 0.00008) at hour 5, resulting in a 4.6-fold reduction from the hour 1 sample to the hour 5 
sample. A mean DFR was calculated as 0.0012 (±0.014) μg cyfluthrin/cm2 for the time course of 
the experiment (hours 1-5) following application at rate of 0.02 kg a.i./ha (12.3 oz. a.i./1000ft2). 
Post-application irrigation reduced the availability of DFR 16.5-fold at hour 1, 29-fold at hour 2, 
and 9.2-fold at hour 5. Post application irrigation reduced the mean DFR over hours 1-5 
from0.02 (±0.014) μg/cm2 to 0.0012 (±0.014) μg/cm2, a 16.6-fold reduction in mean DFR. 
    Without irrigation, DFR of cyfluthrin declined from 0.085 μg/cm2 (± 0.026) at 0.25-hours post-
application to 0.038 μg/cm2 (± 0.026) at hour 1 (a 55% reduction), and then to 0.0046μg/cm2 (± 
0.0008) at hour 5, and an 18.5-fold reduction from hour 0.25 to hour 5. Unfortunately, there is 
no data at 0.25 hours with irrigation, so no direct comparison can be made. 
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Figure 5: Availability of cyfluthrin dislodgeable foliar residues (DFR) with and without post-
application irrigation over the first five hours following application. 
 
3.1.6 2,4-D DFR 
     Dissipation of 2,4-D DFR was rapid over the first hour of the experiment (Fig. 6). DFR of 2,4-D 
declined from 0.12 μg/cm2 (± 0.018) at hour 1 to 0.04 μg/cm2 (± 0.014) at hour 2 (a 3-fold 
reduction) and then to 0.009 μg/cm2 (± 0.007) at hour 5, resulting in a 13.3- fold reduction in 
available residues from hour 1 to 5. A mean DFR was calculated as 0.056 (±0.037) μg 2,4-D/cm2 
for the time course of the experiment (hours 1-5) following application at a rate of 0.26 kg 
a.i./ha (0.086 oz. a.i./1000ft2).  
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Figure 6: Availability of 2,4-D dislodgeable foliar residues (DFR) over the first five hours following 
application. 
 
 
3.1.7 Halofenozide DFR 
     The dissipation pattern of halofenozide from hours 1 to 5 was consistent with previous 
results (Fig. 7).  DFR of halofenozide declined from 0.276 μg/cm2 (± 0.078) at hour 1 to 0.047 
μg/cm2 (± 0.000098) at hour 2, resulting in a 5.9-fold reduction of available residues over the 
first hour. Available residues then decreased to 0.023 μg/cm2(± 0.010) at hour 5, for a 12-fold 
reduction over the time course of the experiment. A mean DFR was determined to be 0.115 
μg/cm2 (±0.022) for the time course of the experiment (hours 1-5) following application at a rate 
of 1.9 kg a.i./ha (0.65 oz. a.i./1000ft2).  
     The dissipation pattern of halofenozide between hours 0.25 and 1 was not consistent with 
previous results. Halofenozide residues did not significantly decline in the first hour following 
application. Dislodgeable foliar halofenozide residues only declined from 0.295 μg 
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halofenozide/cm2 (± 0.067) at 0.25 hours to 0.276 μg/cm2 (± 0.065) at hour 1 and this reduction 
was not significantly different.       
 
 
Figure 7: Availability of halofenozide dislodgeable foliar residues (DFR) over the first five hours 
following application. 
 
3.1.8 Imidacloprid DFR 
     The dissipation of DFR of imidacloprid followed a similar pattern to most previous 
compounds (Fig. 8). DFR of imidacloprid declined from 0.003 μg/cm2 (± 0.0007) at 0.25 hours to 
0.0007 μg/cm2 (± 0.0002) at hour 1 (a 4.3-fold reduction) and then to 0.00004 (±0.00002) at 
hour 5, resulting in a 75-fold reduction in available residues from hours 0.25 to 5. DFR of 
imidacloprid declined from 0.0007 μg/cm2 (± 0.0002) at hour 1 to 0.00005 μg/cm2 (± 0.00003) at 
hour 2, a 14-fold reduction, before declining to 0.00004 (±0.00002) at hour 5, resulting in a 17.5-
fold reduction in available residues over the time course of the experiment (hours 1-5). A mean 
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DFR was calculated as 0.0005 (±0.0003) μg imidacloprid /cm2 for the time course of the 
experiment (hours 1-5) following application at a rate of 0.00011 kg/ha (0.035 oz. a.i./1000ft2).   
 
Figure 8: Availability of imidacloprid dislodgeable foliar residues (DFR) over the first five hours 
following application. 
3.1.9 MCPP-p DFR 
     Dissipation of DFR of MCPP-p followed a similar pattern as for the compounds above (Fig. 9). 
DFR of MCPP-p declined from 0.31 μg/cm2 (± 0.12) at hour 1 to 0.075 μg/cm2 (± 0.045) at hour 2 
(a 4.1-fold reduction) and then to 0.012 μg/cm2 (± 0.007) at hour 5, resulting in a 25.8-fold 
reduction of available residues from hour 1 to 5. A mean DFR was calculated as 0.132 (±0.16) μg 
MCPP-p/cm2 for the time course of the experiment (hours 1-5) following application at a rate of 
0.41 kg/ha (0.13oz. a.i./1000ft2).  
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Figure 9: Availability of MCPP-p dislodgeable foliar residues (DFR) over the first five hours 
following application. 
 
3.1.10 Summary of DFR Results 
DFR results are summarized in Table 9. Residues declined over a range of 50% (carfentrazone-
ethyl) to 25.8-fold (MCPP-p) between hours 1-5, the time of the play of simulated golf. 
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Table 9. Dissipation of test pesticides over time from greatest to least reduction between hours 
1-5. Mean DFR in μg/cm2 (with loss from previous sample), total loss over hours 1-5 (time course 
of the experiment) and mean DFR from hours 1-5, used to calculate dermal dose.  
 
Pest, pesticide, Hr, Hour, Azox, azoxystrobin, Carf, carfentrazone-ethyl, CHT, chlorothalonil, CYF, 
cyfluthrin with irrigation, CYF w/o, cyfluthrin without irrigation, Halo, halofenozide, Imid, 
imidacloprid. 
 
3.2 Determination of Exposure by Dosimetry 
 
3.2.1 Dosimetry Method Performance 
     Each extraction included a daily matrix blank (untreated dosimetry suit segment) and fortified 
matrix spike (dosimetry suit segment amended with the analyte of interest).  Briefly, a 1.0 ml 
aliquot of an analytical standard solution was added to the dosimetry suit segment in an amber 
glass bottle.  The sample was left in the hood uncapped for 1 hour to allow the solvent to 
evaporate. The extraction then proceeded as with the samples.  
1) Azoxystrobin Dosimeter 
      Spike recoveries for the azoxystrobin dosimetry segments averaged 105.9% (± 8.7%, 
N=8) and ranged from 90.5% for the pants to 117.2% for the upper arm.   
2) Carfentrazone-ethyl Dosimetry 
     Carfentrazone-ethyl recoveries from dosimetry segments averaged 96.7% and ranged 
from 84.2% for the upper arm to 112.4% for the Torso (± 11.3%, N =8).  
Pest. Hr 0.25 
 
DFR Hr 1 
 
DFR Hr 2 
 
DFR Hr 5 
 
Rdcn. 
 Hour 1-5 
Mean 
DFR  
Hr 1-5 
MCPP-p NA 0.31 0.12 (61%) 0.012 (10-fold) 25.8-fold 0.15 
Imid 0.003 0.0007 (4.3-fold) 0.00005 (14-fold 0.00004 (20%) 17.5-fold 0.0005 
Azox 0.60 0.34 (43%) 0.07 (4.9-fold) 0.02 (3.5-fold) 17-fold 0.146 
2,4-D NA 0.12 0.04 (3-fold) 0.009 (4.4-fold) 13.3-fold 0.056 
Halo 0.295 0.276 (6.4%) 0.047 (5.9-fold) 0.023 (2-fold) 12-fold 0.115 
CHT 5.83 2.89 (50%) 1.2 (2.4-fold) 0.35 (3.4-fold) 8.3-fold 1.48 
CYF w/o 0.085 0.038 (55%) 0.016 (2.4-fold) 0.0046 (3.5-fold) 8.3-fold 0.020 
CYF NA 0.0023  0.0007 (70%) 0.0005 (28%) 4.6-fold 0.0012 
Carf 0.00082 0.00052 (37%) 0.0004 (23%) 0.00026 (35%) 50% 0.0004 
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3) Chlorothalonil Dosimetry 
    Chlorothalonil recoveries from dosimetry segments averaged 92.8% and ranged from 82.3% 
for the upper arm to 120.0% for the gloves (± 19.2%, N =8).  
4) Cyfluthrin Dosimetry 
    Cyfluthrin recoveries from dosimetry segments averaged 89.7% and ranged from 80.2% for 
the pants to 107.9% for the veil (± 8.9%, N =8).  
5) 2,4-D Dosimetry 
    2,4-D recoveries from dosimetry segments averaged 106.7% and ranged from 86.4% for 
Lower Leg, to 125.7% for Torso (± 22.3%, N =8).  
6) Halofenozide Dosimeter 
    Spike recoveries for the halofenozide dosimetry segments averaged 83.2% (± 16.3%, N=8) and 
ranged from 76.5% for the pants to 98.6% for the upper sock.   
7) Imidacloprid Dosimetry 
    Imidacloprid recoveries from dosimetry segments averaged 95.3% ranged from 86.5% for the 
torso, to 117.8% for the veil (± 15.6%, N=8). 
8) MCPP-p Dosimetry 
    MCPP-p recoveries from dosimetry segments averaged 97.4% ranged from 76.5% for the 
upper arm, to 123.6% for the pant (± 13.1%). 
3.2.2 Azoxystrobin Dosimetry 
     The distribution of azoxystrobin on the various dosimeter segments of the whole-body 
dosimeter suit is shown in Figure 9. An average of 804.7 µg (±152.1 µg) of azoxystrobin was 
found on the dosimeters following three separate applications without post-application 
irrigation. The hands were the primary route of exposure to azoxystrobin, accounting for ~ 56% 
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of the total residues, and with the upper sock (~ 27%) accounted for ~ 83% of the total 
pesticide residues transferred to the dosimeter. The remaining dosimeter segments (veil, upper 
and lower arm, torso, pant and lower leg) accounted for ~ 17% of the total residues combined. 
3.2.3 Carfentrazone-ethyl Dosimetry 
     Carfentrazone-ethyl distribution on the dosimeter segments is shown in Figure 11. An 
average of 2.8 µg (± 1.24 µg) was found on the dosimeters following two separate applications 
without post-application irrigation.  Only the gloves and pants had residues on all samples. The  
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Azoxystrobin Distribution on Dosimeter (Percent of Total) 
 
 
Figure 10: Distribution of azoxystrobin on dosimetry suits following the play of simulated rounds 
of golf. 
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Carfentrazone-ethyl Distribution on Dosimeter (Percent of Total) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: Distribution of carfentrazone-ethyl on dosimetry suits following the play of simulated 
rounds of golf. Hashed sections (         ) and * indicate segments where no residues were 
detected (ND). For purposes of determining exposure, segments that were ND were assigned a 
residue amount equal to the limit of detection. 
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the detection limit.  Again, the hands (~ 28% of transferable residues) were the primary route of 
exposure with the pants having the next highest level of residues at ~ 22%. These two segments 
account for ~ 50% of all dermal residues of carfentrazone-ethyl.   
3.2.4 Chlorothalonil Dosimetry 
     An average of 10,241 μg (±3042) of chlorothalonil was found on the whole-body dosimeters 
following three separate applications without post-application irrigation. All samples were 
positive for chlorothalonil. The hands were again the principle route of exposure to 
chlorothalonil, accounting for ~ 59% of the total dermal exposure (Fig. 12). The lower leg (~ 
15%) and the upper sock (~ 15%) account for an additional ~ 30% of the dosimeter residues. 
The rest of the dosimeter (veil, upper arm, lower arm, torso, and pant) contained ~ 11% of the 
total dermal residues combined. 
3.2.5 Cyfluthrin Without Irrigation Dosimetry 
     An average of 83.9 (± 17.8) μg of cyfluthrin was found on the whole-body dosimeter 
segments following three separate applications of cyfluthrin without post-application irrigation. 
Gloves, pants, lower leg and upper sock were consistently positive for cyfluthrin. All other 
segments were consistently negative. The hands were again the principle route of exposure, 
accounting for ~ 43% of the total dermal exposure (Fig. 13). The upper sock (~27%) and lower 
leg (~19%) accounted for an additional ~ 46% of the dosimeter residues.   
 
 
 
 
58 
 
 
 
Chlorothalonil Distribution on Dosimeter (Percent of Total) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12: Distribution of chlorothalonil on dosimeters following the play of simulated rounds of 
golf. 
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Cyfluthrin (without irrigation) Distribution on Dosimeter 
(Percent of Total) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: Distribution of cyfluthrin without post-application irrigation on dosimeters following 
the play of simulated rounds of golf. Hashed sections (          ) and * indicate segments where no 
residues were detected (ND). For purposes of determining exposure, segments that were ND 
were assigned a residue amount equal to ½ of the limit of detection. 
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3.2.6 2,4-D Dosimetry 
     An average of 332 μg (± 130.8 μg) of 2,4-D was found on the whole-body dosimeters 
following three separate applications without post-application irrigation. All samples were 
positive for 2,4-D. The hands were again the principle route of exposure, accounting for ~ 64% 
of the total dermal exposure (Fig. 14). The upper sock accounted for an additional ~ 18% of the 
dosimeter residues.  
3.2.7 Halofenozide Dosimetry 
     An average of 944 (±249) μg of halofenozide was found on the whole-body dosimeters 
following three separate applications without post-application irrigation. All samples were 
positive for halofenozide. The hands were again the principle route of exposure to halofenozide, 
accounting for ~ 54% of the total dermal exposure (Fig. 15). The lower leg (~ 17%) and the 
upper sock (~ 13%) account for an additional ~ 30% of the dosimeter residues. The rest of the 
dosimeter (veil, upper arm, lower arm, torso, and pant) contained ~ 16% of the total dermal 
residues combined. 
3.2.8 Imidacloprid Dosimetry 
     An average of 3.15 μg (± 1.47 μg) of imidacloprid was found on the whole-body dosimeter 
segments following three separate applications with post-application irrigation. All hand, lower 
arm, lower leg and upper sock samples were positive for imidacloprid. All other samples were 
negative. The hands were again the principle route of exposure, (~ 49%, Fig. 16), and with the 
lower leg (~33%) account for ~82% of the total exposure. 
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Fig. 14: Distribution of 2,4-D on dosimeter suits following the play of simulated rounds of golf. 
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Figure 15: Distribution of halofenozide on dosimeter segments following the  
play of simulated rounds of golf  
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Imidacloprid Distribution on Dosimeter (Percent of Total) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16: Distribution of imidacloprid on dosimetry suits following the play of simulated rounds 
of golf. Hashed sections (         ) and * Indicate segments where no residues were detected (ND). 
For purposes of determining exposure, segments that were ND were assigned a residue amount 
equal to ½ of the limit of detection. 
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3.2.9 MCPP-p Dosimetry 
     An average of 772 μg (±193 μg) of MCPP-p was found on the whole-body dosimeters 
following three separate applications without post-application irrigation. All samples were 
positive for MCPP-p. The hands were again the principle route of exposure, accounting for ~ 
71% of the total dermal exposure (Fig. 166). The upper sock accounted for an additional ~ 12% 
of the dosimeter residues.   
3.2.10 Summary of Dosimetry Results 
Table 10 shows the percentage of pesticides found on the hands, upper socks and lower legs as 
a percentage of the total amount found on the dosimeter. These dosimetry segments contained 
the bulk of the residues. 
Table 10. Pesticide residues found on hands, socks and lower leg, and the sum of all three 
expressed as a percentage of the total found on the dosimeter in decreasing order of percent on 
the segments. 
 
Pesticide Application rate % hands % sock/lower leg Total % hands, 
sock/lower leg 
Imidacloprid 0.45 kg a.i./ha 48.6 % 43.6 % 92.2 % 
MCPP-p 0.41 kg a.i./ha 70.6 % 20.0 % 90.6 % 
Chlorothalonil 12.7 kga.i./ha 58.9 % 30.5 % 89.4 % 
Cyfluthrin w/o 0.02 kg a.i./ha 43.1 % 46.2 % 89.3 % 
2,4-D 0.26 kg a.i./ha 64.0 % 24.6 % 88.6 % 
Azoxystrobin 0.65 kg a.i./ha 55.9 % 32.1 % 88.0 % 
Halofenozide 1.9 kg a.i./ha 54.4 % 29.8 % 84.2 % 
*Carfentrazone-ethyl 0.00011 kg a.i./ha 28.0 % 14.1% 42.1 % 
*Only the hands and upper sock had detectable residues of carfentrazone-ethyl. Estimated 
concentrations based on the limit of detection were assigned to all segments with non-
detectable residues, including the lower leg for carfentrazone-ethyl. This procedure artificially 
lowered the percentage on the hands and upper sock/lower leg. 
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Figure 17: Distribution of MCPP-p on dosimeter segments following the play of simulated rounds 
of golf. 
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3.3 Personal Air Samplers 
3.3.1 Personal Air Sampler Method Performance 
     Sorbent from the front and back sections of the personal air samplers were amended with 
100 µl of solvent containing the analyte of interest, allowed to air dry for 30 minutes , and 
extracted concurrently with the field collected samples. 
1) Azoxystrobin Air Samplers 
     Spike recoveries of azoxystrobin from the personal air samplers averaged 87.3% (± 4.9%, 
N=4). 
2) Carfentrazone-ethyl Air Samplers 
     Spike recoveries of carfentrazone-ethyl from the personal air samplers averaged 89.7% (± 
7.9%, N=4). 
3) Chlorothalonil Air Samplers 
     Spike recoveries of chlorothalonil from the personal air samplers averaged 91.3% (± 4.2%, 
N=4). 
4) Cyfluthrin Air Samplers 
     Spike recoveries of cyfluthrin from the personal air samplers averaged 87.4% (± 6.3%, N=4). 
5) 2,4-D Air Samplers 
     Spike recoveries of 2,4-D from the personal air samplers averaged 96.3% (± 3.1%, N=4). 
6) Halofenozide Air Samplers 
     Spike recoveries of halofenozide from the personal air samplers averaged 95.7% (± 10.8%, 
N=4). 
7) Imidacloprid Air Samplers 
     Spike recoveries of imidacloprid from the personal air samplers averaged 104.5% (± 18.1%, 
N=4). 
8) MCPP-p Air Samplers 
     Spike recoveries of MCPP-p from the personal air samplers averaged 96.1% (± 3.9%, N=4). 
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3.3.2 Personal Air Sampler Results 
     Personal air samplers were worn by the dosimetry group during the play of a 4-hour round of 
simulated golf. Pesticide residues were analyzed to determine inhalation exposure during the 
experiment. Inhaled dose was determined by multiplying the amount of pesticide found on the 
air sampler (sampled at 2 L/min) by 10.5 (to adjust to a moderate breathing rate of 21 L/min) 
(Eqn. 6). 
Eqn. 6     Inhaled Dose = residues in air sampler (µg) x 10.5 
 
3.3.2.1 Azoxystrobin Air Samplers 
     Analysis of the quartz filter and first section of sorbent of personal air samplers following 
application of azoxystrobin without post-application irrigation resulted in an inhaled dose of 
0.08 µg (± 0.045 µg) over the 4-hour simulated round of golf, assuming a moderate breathing 
rate (21 L/min). Azoxystrobin was never detected in the second section of sorbent, indicating 
that no breakthrough had occurred during sampling. 
3.3.2.2 Carfentrazone-ethyl Air Samplers 
     Analysis of the quartz filter and first section of sorbent of personal air samplers worn by the 
dosimetry group following application of carfentrazone-ethyl without post-application irrigation 
resulted in no detectable residues on the sorbent or filter. An inhaled dose of 0.002 µg, based 
on ½ of the limit of detection, was assigned for the 4-hour simulated round of golf, assuming a 
moderate breathing rate (21 L/min). Carfentrazone-ethyl was never detected in the second 
section of sorbent. 
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3.3.2.3 Chlorothalonil Air Samplers 
     Analysis of the quartz filter and first section of sorbent of personal air samplers worn by the 
dosimetry group following application of chlorothalonil without post-application irrigation 
resulted in an inhaled dose of 29.8 µg (± 14.9 µg) over the 4-hour simulated round of golf, 
assuming a moderate breathing rate (21 L/min). Chlorothalonil was never detected in the 
second section of sorbent. 
3.3.2.4 Cyfluthrin Without Irrigation Air Samplers  
     Analysis of the quartz filter and first section of sorbent of personal air samplers worn by the 
dosimetry group following application of cyfluthrin without post-application irrigation resulted 
in no detectable residues on the sorbent or filter. An inhaled dose of 0.05 µg, based on ½ of the 
limit of detection, was assigned for the 4-hour simulated round of golf, assuming a moderate 
breathing rate (21 L/min). Cyfluthrin was never detected in the second section of sorbent. 
3.3.2.5 2,4-D Air Samplers 
     Analysis of the quartz filter and first section of sorbent of personal air samplers worn by the 
dosimetry group following application of 2,4-D with post-application irrigation resulted in no 
detectable residues on the sorbent or filter. An inhaled dose of 0.0005 µg, based on ½ of the 
limit of detection, was assigned for the 4-hour simulated round of golf, assuming a moderate 
breathing rate (21 L/min). 2,4-D was never detected in the second section of sorbent. 
3.3.2.6 Halofenozide Air Samplers 
     Analysis of the quartz filter and first section of sorbent of personal air samplers worn by the 
dosimetry group following application of halofenozide without post-application irrigation 
resulted in an inhaled dose of 0.09 µg (± 0.08 µg) over the 4-hour simulated round of golf, 
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assuming a moderate breathing rate (21 L/min). Halofenozide was never detected in the second 
section of sorbent. 
3.3.2.7 Imidacloprid Air Samplers 
     Analysis of the quartz filter and first section of sorbent of personal air samplers worn by the 
dosimetry group following application of imidacloprid with post-application irrigation resulted in 
no detectable residues on the sorbent or filter. An inhaled dose of 0.0026 µg, based on ½ of the 
limit of detection, was assigned for the 4-hour simulated round of golf, assuming a moderate 
breathing rate (21 L/min). Imidacloprid was never detected in the second section of sorbent. 
3.3.2.8 MCPP-p 
Analysis of the quartz filter and first section of sorbent of personal air samplers worn by the 
dosimetry group following application of MCPP-p without post-application irrigation resulted in 
an inhaled dose of 0.0034 µg (± 0.0012 µg) over the 4-hour simulated round of golf, assuming a 
moderate breathing rate (21 L/min). MCPP-p was never detected in the second section of 
sorbent. 
Table 11. Summary of inhaled dose and dose used for hazard evaluation.  
Pesticide Inhaled Dose Dose used for Hazard Evaluation 
Azoxystrobin 0.08 µg 0.08 µg 
Carfentrazone-ethyl ND (LOD = 0.004 µg) 0.002 µg 
Chlorothalonil 29.8 µg 28.9 µg 
Cyfluthrin ND (LOD = 0.1 µg) 0.05 µg 
2,4-D ND (LOD = 0.001 µg) 0.0005 µg 
Halofenozide 0.09 µg 0.09 µg 
Imidacloprid ND (LOD = 0.0052 µg) 0.0026 µg 
MCPP-p 0.0034 µg 0.0034 µg 
ND = not detected in any sample. A dose of ½ the LOD was assumed for samples that were ND. 
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3.4 Transfer Factors 
     Transfer factors (TF) were calculated according to the method of Zweig et al (1985). The 
transfer factor is the ratio between DFR and residues found on the dosimeters (Eqn. 7). It is 
calculated as follows: 
Eqn. 7                            TF (cm2/hr) = Dermal exposure (µg)/ DFR (µg/cm2)/4 hr 
Using azoxystrobin as an example, we can calculate a TF as follows 
 
Eqn. 8                                    Azoxystrobin TF = 805 μg/0.146 μg/cm2/4h 
 
Eqn. 9                                             Azoxystrobin TF ~ 1390 cm2/hr 
 
     Transfer factors were calculated for each compound (Table 12). A transfer factor could not be 
calculated for cyfluthrin with irrigation as there were no detectable residues on the dosimeters.  
Table 12. Transfer Factors (TF) were calculated for the pesticides used in the study. TF (cm2/hr) = 
Dermal exposure (µg)/ DFR (µg/cm2)/4 hr in order of highest to lowest TF.  
 
Pesticide Transfer Factor 
Halofenozide 2207 (± 341) 
Carfentrazone-ethyl 1814(± 457)  
Imidacloprid 1575 (± 736) 
2,4-D 1482 (± 307) 
Cyfluthrin w/o 1467 (± 1196) 
MCPP-p 1462 (± 263) 
Chlorothalonil 1398 (± 451) 
Azoxystrobin 1390 (± 199) 
Cyfluthrin ND 
ND = no detectable residues on the dosimeter. 
 
     Rearranging this equation, we can determine the dermal dose using an experimentally-
derived DFR (Eqn. 6) and select the appropriate transfer factor. 
Eqn. 10                       Dermal exposure (µg) = TF (cm2/hr) x DFR (µg/cm2)/ 4 hr 
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This process allows us to calculate dermal exposure using the residue data from relatively easily 
obtained and inexpensive DFR samples. 
 
3.5 Biomonitoring 
3.5.1 Biomonitoring Method Performance 
     Blank urine samples were amended with the analyte of interest and concurrently extracted 
with the field samples on each day of analysis. 
Carfentrazone-ethyl Urine Samples 
     Recoveries of carfentrazone chloropropionic acid from amended urine samples was 87.4%, (± 
8.3%, N=8). 
Chlorothalonil Urine Samples 
    Recoveries of chlorothalonil from amended urine samples was 88.6%, (± 7.2%, N=3). 
Cyfluthrin Urine Samples 
    Recoveries of cyfluthrin metabolites from amended urine samples are as follows: 
    DBCA - 84.9% (±11.3%, N=3) 
    FPBA – 102.4% (±6.8%, N=3) 
    FPBA-OH – 91.7% (±16.7%, N=3) 
2,4-D Urine Samples 
     Recoveries of 2,4-D from amended urine samples was 101.8%, (± 8.5%, N=8). 
Imidacloprid Urine Samples 
    Imidacloprid recoveries from amended urine samples was 91.2%, (± 9.4%, N=3). 
    6-chloronicotinic acid recoveries from amended urine samples was 84.6%, (± 11.1%, N=3). 
MCPP-p Urine Samples 
Recoveries of MCPP-p from amended urine samples was 105.3%, (± 8.3%, N=8). 
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3.5.2 Biomonitoring Results 
3.5.2.1 Azoxystrobin 
     Azoxystrobin was not analyzed for urinary metabolites due to the lack of an abundant urinary 
metabolite and reliable pharmacokinetic data, and the unavailability of analytical standards for 
these metabolites. 
3.5.2.2 Carfentrazone-ethyl 
     The principal urinary metabolite of carfentrazone-ethyl is carfentrazone chloropropionic acid 
(CCA) (Metabolism Study OTS 798.7485 [§81.5], FMC Corp.). This study found that 38.16% of the 
administered oral dose was eliminated in the urine in the first 24 hours. Therefore, 24 hour pre- 
and 24-hour post-application urine samples were collected. 
     Carfentrazone chloropropionic acid was not detected in any of the samples, either pre- or 
post-exposure. Therefore, exposure estimates are based using the limit of detection, which was 
2.5 µg/L urine. This procedure resulted in calculated doses ranging from 1.98 to 10.2 ug, with a 
mean of 7.3 (± 0.91) µg carfentrazone-ethyl (Eqn. 10).  
 
Eqn. 10  Dose (µg) = 2.5 µg/L (LOD) x 1.12 L (average urine volume) = 7.3 µg carfentrazone-ethyl 
          0.3816 (38.16% of absorbed dose in urine as CCA) 
 
    The calculated dose from each individual was divided by 80 kg (USEPA exposure factors 
handbook) giving an estimated absorbed dose of 0.09 (± 0.01) µg/kg/d. 
3.5.2.3 Chlorothalonil 
     While thiol-substituted chlorothalonil metabolites have been detected in laboratory animals 
at low levels in urine (~5% of total metabolites, 62,63), these metabolites are not commercially 
available.  An attempt was made to determine parent Chlorothalonil in urine following the 
method of Aprea et al (53) in the pre- and post-application urine samples. This study attempted 
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to correlate doses determined from environmental media (dosimetry pads, air samplers) to 
urinary excretion of the parent compound in greenhouse workers exposed to chlorothalonil. 
This approach proved unsuccessful due to a lack of correlation between environmental residues 
and urinary excretion, and high levels of chlorothalonil in pre-samples of the greenhouse 
workers. It was suggested that contamination may have occurred during sample collection. 
Interestingly, in our experiment all urine samples were negative for chlorothalonil but one. It 
was later determined that this volunteer had applied chlorothalonil to a flower crop after their 
exposure during simulated golf. The positive detection could have occurred due to the increased 
exposure they received following the flower application, or they may have contaminated the 
sample following the application of chlorothalonil to the flower crop. The limit of detection was 
0.2 µg/L. No attempt was made to establish an estimated dose based on biomonitoring due to 
the lack of pharmacokinetic data. 
3.5.2.4 Cyfluthrin 
     Cyfluthrin metabolites methyl 4-fluoro-3-phenoxybenzoate (FPBA), 4-fluoro-3-(4-
hydroxyphenoxy)-benzoic acid (FPBA-OH), and methyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclo-
propanecarboxylate (DBCA) were monitored in the urine of the biomonitoring volunteers. These 
metabolites were never detected in the urine of the volunteers either pre-application or 
following cyfluthrin application with or without irrigation. The LOD for cyfluthrin was 2.0 µg/L. A 
study in rats found that 55-70% of an orally administered dose of cyfluthrin was eliminated in 
the urine in 24 hours (64). Using the high end of this range (i.e., 70%), the calculated doses 
ranged from 2.6 to 5.2 µg with an average of 3.6 (± 1.1) µg.  
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Cyfluthrin 
Eqn. 11 Dose (µg) = 2.0 µg/L (LOD) x 1.26 L (average volume of urine) = 3.6 µg cyfluthrin 
            0.7 (70% of absorbed dose in urine as metabolites) 
 
 
The calculated dose from each individual was divided by 80 kg, giving an estimated average 
absorbed dose of 0.05 (±0.017) µg/kg/d. 
3.5.2.5 2,4-D 
    The phenoxy herbicide 2,4-D is excreted in the urine primarily as unaltered parent compound 
(65). Harris et al (66) evaluated three previous studies of urinary clearance of 2,4-D following a 
single dermal exposure to the palm, hand, or forearm. The results indicated that 11% of the 
dose was excreted in the first day, 21% in the second day, and 27% in the third day. Since the 
principle route of golfer exposure to 2,4-D is through the hand and upper sock area (lower calf), 
it seems appropriate to use the clearance data from all three regions. Over the three days, we 
should collect 59% of the dose (sum of days 1, 2 and 3). The limit of detection is 1.0 µg/L based 
on 2 L/day urine output. Urine output can vary greatly, so detection limits can be lower or 
higher for individual samples. Daily volumes collected for 2,4-D and MCPP-p ranged from 630.0 
to 2107.8 ml. 
     Three biomonitoring subjects had positive pre-samples, all very close to the detection limit. 
One subject had 0.83 µg (±0.05) of 2,4-D in their pre-sample before application 1, and two 
subjects had positive urine samples before application 2 containing 0.74 (±0.04) and 0.88 (±0.07) 
µg, respectively. These amounts were subtracted from the respective individual’s day 1 samples. 
2,4-D was not detected in any of the pre-samples for application 3.            
     The phenoxy herbicide 2,4-D is routinely applied to home lawns, college campuses and parks. 
There are many ways these individuals could have been exposed prior to the experiment.  
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    An average of 0.038 ± 0.018 µg/kg (N=12) was excreted in the first day, 0.077 ± 0.047 µg/kg 
(N=12) in the second day and 0.046 ± 0.020 µg/kg (N=12) on the third day, for a total of 0.161 
µg/kg. Of the total amount recovered in the three days of this experiment, 23.6% was on the 
first day, 47.8% on the second day, and 28.6% on the third.  
     An example calculation from one day for one volunteer follows. The analytical results in 
µg/ml urine are multiplied by the total amount of urine to arrive at the amount excreted (Eqn. 
12).  
Eqn. 12                      0.0039 µg 2,4-D/ml urine x 726.8 ml urine = 2.83 µg 2,4-D.  
 
     We then sum the doses from days 1,2 and 3, (e.g. 2.13 µg (D1), 2.83 µg (D2), 1.87 µg (D3) for 
this volunteer) to arrive at the total amount excreted, 6.83 µg. This amount represents an 
estimated 59% of the absorbed dose, so to calculate the total absorbed dose, we divide this 
measured concentration by 59% (percent of dose excreted days 1-3) (Eqn. 13). 
 Eqn. 13                                 6.83 µg/0.59 = 11.58 µg estimated dose 
 
     We then divide the estimated dose by the weight of the volunteer to arrive at a dose of 0.187 
µg/kg/d for this volunteer (Eqn. 14) acquired from this exposure. 
Eqn. 14                                             11.58 µg/62 kg = 0.187 µg/kg/d 
 
    Using the estimated doses by weight from all four volunteers, the average total absorbed 
dose of 2,4-D is 0.273 ±0.121 µg/kg/d (N=12).  
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3.5.2.6 Halofenozide 
     Halofenozide was not analyzed for urinary metabolites due to the lack of an abundant urinary 
metabolite and reliable pharmacokinetic data, and the unavailability of analytical standards for 
these metabolites. 
3.5.2.7 Imidacloprid 
     Parent imidacloprid and its metabolite 6-chloronicotinic acid (6-CNA) were monitored in the 
urine of the biomonitoring volunteers. In a study by Klein and Karl (67), ~ 15% of the dose of 
imidacloprid was excreted in the rat as parent imidacloprid, and ~28% was excreted as 6-CNA 
and 6-CNA-glycine in the first 24 hours after dosing. Hydrolysis of the glycine metabolite gives us 
28% of the dose as 6-CNA, and added to the 15% of the dose from parent imidacloprid we can 
account for ~43% of the dose.   Neither imidacloprid nor 6-CNA were found in any of urine 
samples, either pre- or post-exposure.  The limit of detection for imidacloprid was 1.0 µg/L, and 
2.5 µg/L for 6-CNA.  To achieve a urinary concentration of 1.0 µg/L imidacloprid, an absorbed 
dose of 10 µg imidacloprid is required, based on the average 1480 ml urine collected from the 
volunteers (Eqn. 15). Performing the same calculation for 6-CNA, a dose of 13.4 µg imidacloprid 
is required (Eqn. 16).  
Imidacloprid 
Eqn. 15 Absorbed dose (µg) = 1.0 µg/L (LOD) x 1.5 L (avg. volume of urine) = 10 µg imidacloprid 
            0.15 (15% of absorbed dose in urine as imidacloprid) 
 
6-CAN 
Eqn. 16 Absorbed dose (µg) = 2.5 µg/L (LOD) x 1.5 L (avg. volume of urine) = 13.4 µg imidacloprid 
             0.28 (28% of absorbed dose in urine as 6-CNA) 
 
    Using the limit of detection for imidacloprid parent in urine, we can estimate an absorbed 
dose of <10µg. Dividing this by 80 kg (68) gives us an estimated dose of 0.125 µg/kg/d. 
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3.5.2.8 MCPP-p 
     MCPP-p was not detected in any of the pre-samples. There are no pharmacokinetic data 
available for MCPP-p so we are unable to back calculate directly to the exposed dose. The total 
average amount of MCPP-p excreted in the urine of the volunteers over three days was 0.748 
±0.473 µg/kg (N=12).  An average of 0.160 ± 0.108 µg/kg (N=12) was excreted in the first day, 
0.408 ± 0.326 µg/kg (N=12) in the second day and 0.180 ± 0.102 µg/kg (N=12) in the third day. 
Of the total amount recovered in the three days of this experiment, 21.4% was on the first day, 
54.6% on the second day, and 24.1% on the third. These results are similar to 2,4-D above. The 
physicochemical properties (water solubility, Kow, Koc) of MCPP-p are similar to 2,4-D, and the 
urinary elimination pattern appears also to be similar, so we used the 2,4-D dermal clearance 
data for estimating the dose. We assumed that we captured 59% of the dose from the three-day 
urine collection, so the calculated average total absorbed dose is 1.27 (±0.80) µg/kg/d (N=12) 
(0.748 µg/kg /0.59 (59%) =1.27 µg/kg/d).  
3.6 Risk Assessment 
 
3.6.1 Summary of Risk Assessment 
    We used the USEPA Hazard Quotient (HQ) and Margin of Exposure (MOE) methodologies for 
determining risk associated with golfer exposure to pesticides. Tables 13 and 14 list the 
calculated HQs and MOEs in decreasing order of hazard using dosimetry and biomonitoring 
results, respectively. 
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Table 13. Hazard quotients (HQ) and Margins of Exposure (MOE) for the test pesticides as 
determined by dosimetry following simulated rounds of golf, in decreasing order of HQ. 
 
F, Fungicide, H, Herbicide, I, Insecticide, C, Chronic NOAEL and RfD used, L, LOAEL used. 
 
 
 
Table 14. Hazard quotients (HQ) and Margins of Exposure (MOE) for the test pesticides as 
determined by biomonitoring following the play of simulated rounds of golf. 
 
F = Fungicide, H = Herbicide, I = Insecticide, ND = all samples were ND, ½ of the limit of detection  
used. NA = Not Analyzed. 
  
 
 
 
 
 
Pesticide 
NOAEL 
µg/kg/d 
RfD 
µg/kg/d 
Dosimetry 
Dose µg/kg/d  HQ MOE 
Halofenozide (I,C)  3800 38 2.36 (±0.62) 0.062 (C) 1610 (C) 
Cyfluthrin (I) 2500 20 0.053 (±0.011) 0.0027 47,170  
Chlorothalonil (F) 175,000 583 0.55 (± 0.16)  0.0009 318,182 
MCPP-p (H) 175,000 1750 0.97 (± 0.35) 0.0006 182,291 
Azoxystrobin (F), (L) 200,000 
(L) 
670 0.40 (±0.08) 0.0006 500,000 
2,4-D (H) 67,000 670 0.42 (±0.16) 0.0006 161,466 
Imidacloprid (I) 42,000 140 0.0029 (± 0.0014) 0.00002 14,482,2
75 Carfentrazone-ethyl 
(H) 
500,000 5000 0.004 (±0.0015)  0.0000008 125,000,
000 
 
Pesticide 
NOAEL 
µg/kg/d 
RfD 
µg/kg/d 
Biomonitoring 
Dose µg/kg/d  HQ MOE 
Halofenozide (I,) 3800 38 NA NA  NA 
Cyfluthrin (I) 2500 20 4.0 (ND) < 0.0025 
(ND) 
> 50,000 
(ND) Cyfluthrin w/o (I) 2500 20 4.0 (ND) < 0.0025 
(ND) 
> 50,000 
(ND) Chlorothalonil (F) 175,000 583 NA A A 
MCPP-p (H) 175,000 1750 1.27 (±0.80) 0.00073 137,795 
Azoxystrobin (F) 200,000 
(L) 
670 NA NA NA 
2,4-D (H) 67,000 670 0.27 (±0.12) 0.00041 244526 
Imidacloprid (I) 42,000 140 0.125 (ND) < 0.0009 
(ND) 
> 336,000 
(ND) Carfentrazone-ethyl (H) 500,000 5000 0.06 < 0.00009 
(ND) 
>11,666,667 
(ND) 
((NNNNN(9(
N(ND) 
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3.6.2 Azoxystrobin Risk Assessment 
An acute NOAEL has not been established for azoxystrobin because all tested doses in the 
selected neurotoxicity study induced diarrhea (69). This event was considered treatment 
related, and not dose related. The USEPA has established an acute Lowest Observable Adverse 
Effect Level (LOAEL) of 200 mg/kg/d, and an acute RfD of 0.67 mg/kg/d using this study, with a 
UFA of 10, a UFH of 10 and an FQPA SF (Food Quality Protection Act Safety Factor, protects 
infants and children) of 3 (69). The HQs and MOEs for azoxystrobin were calculated using these 
values. 
3.6.2.1 Dosimetry 
 Since there is no biomonitoring data available for azoxystrobin, the calculations are made with 
only dosimetry data. A total of 804.7 µg (±152.1 µg) azoxystrobin was found on the dosimetry 
suit. The USEPA has established the dermal penetration rate of azoxystrobin at 4% (70). Using 
the 4% penetration rate, an absorbed dermal dose of 32.2 µg azoxystrobin was determined. All 
azoxystrobin air samplers were negative. The limit of detection for the azoxystrobin air sampler 
analysis was 0.00025 µg/4 hours. Using ½ of the detection limit gives us a dose of 0.000125 µg, 
for a combined dose of 32.200013 µg. Dividing this value by 80 kg, a calculated dose of 0.40 
µg/kg/d is obtained for azoxystrobin (Eqn. 17). 
 
Eqn. 17.                 32.2 𝜇𝑔 (± 6.09) ÷ 80𝑘𝑔 = 0.40 (± 0.08) 𝜇𝑔/𝑘𝑔/d 
 
HQ 
We divide the absorbed dose by the reference dose to get our hazard quotient for azoxystrobin 
(Eqn. 18): 
Eqn. 18                           HQ = 0.40 (±0.03)µ𝑔/𝑘𝑔/𝑑 ÷ 670 µ𝑔/𝑘𝑔/𝑑 = 𝟎. 𝟎𝟎𝟎𝟔 
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MOE 
To calculate the MOE, we divide the LOAEL in this case by the absorbed dose (Eqn. 19): 
 
Eqn. 19                  MOE =200000  µ𝑔/𝑘𝑔/𝑑 ÷ 0.40 (±0.03) µ𝑔/𝑘𝑔/𝑑 = 500,000 
 
    HQs and MOEs from dosimetry data for the other compounds are calculated using this 
approach. 
3.6.2.2 Biomonitoring 
 
     The lack of pharmacokinetic data and available metabolite standards preclude us from 
deriving HQs and MOEs for azoxystrobin through biomonitoring. 
3.6.3 Carfentrazone-ethyl Risk Assessment 
 
     The USEPA has established an oral NOAEL of 500 mg/kg/d based on salivation and decreased 
motor activity (71). Using an uncertainty factor of 100, and an FQPA SF of 1, a RfD of 5 mg/kg/d 
was established (71). 
3.6.3.1 Dosimetry 
 
     An average of 2.8 (± 1.24) µg carfentrazone-ethyl was found on the dosimeters. The 
USEPA has not established a dermal penetration rate for carfentrazone-ethyl, but the 
European Commission Health and Consumer Protection Directorate (72) has accepted a 
dermal penetration rate of 10%. Using this value, an absorbed dose of 0.28 µg 
carfentrazone-ethyl is obtained. No carfentrazone-ethyl was detected on the air samplers, 
so we calculate the dose at ½ of the detection limit, or 0.002 µg. Adding these values, a total 
dose of 0.2802 (±0.07) µg carfentrazone-ethyl is calculated. We divide this by 80 kg to get an 
absorbed dose of 0.004 µg/kg/d (Eqn. 20). 
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Eqn. 20                      0.2802 𝜇𝑔 (± 0.11) ÷ 80𝑘𝑔 = 0.004 (± 0.0015) 𝜇𝑔/𝑘𝑔/d 
HQ 
We divide the absorbed dose by the reference dose to get our hazard quotient for 
carfentrazone-ethyl (Eqn 21): 
Eqn. 18            HQ = 0.004 (±0.001)µ𝑔/𝑘𝑔/𝑑 ÷ 5000 µ𝑔/𝑘𝑔/𝑑 = 𝟎. 𝟎𝟎𝟎𝟎𝟎𝟎𝟖 
 
 
MOE 
To calculate the MOE, we divide the NOAEL by the absorbed dose (Eqn. 22): 
 
Eqn. 22       MOE = 500,000 µ𝑔/𝑘𝑔/𝑑 ÷ 0.004  (±0.001) µ𝑔/𝑘𝑔/𝑑 = 125,000,000 
 
3.6.3.2 Biomonitoring 
     All urine samples were negative for carfentrazone-ethyl. We therefore calculate HQs and 
MOEs using the estimated absorbed dose determined at the LOD, 0.06 µg/kg/d and define the 
HQ or MOE as less than (HQ) or greater than (MOE) the value determined using the limit of 
detection, respectively: 
HQ 
We divide the estimated absorbed dose determined at the LOD by the reference dose to get our 
hazard quotient for carfentrazone-ethyl (Eqn. 23): 
Eqn. 23                              HQ = 0.06 µg/kg/d ÷ 670 µg/kg/d = < 0.00009 
 
MOE 
 To calculate the MOE, we divide the NOAEL by the absorbed dose (Eqn. 24): 
 
Eqn. 24  MOE =67000  µ𝑔/𝑘𝑔/𝑑 ÷  0.06 µ𝑔/𝑘𝑔/𝑑 = > 11,666,667 
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     Using these approaches, we calculated HQs and MOEs from biomonitoring data for the other 
remaining compounds. 
3.6.4 Chlorothalonil Risk Assessment 
 
     An acute NOAEL has not been established for chlorothalonil, so the USEPA utilizes a LOAEL of 
175 mg/kg/d (increased cell proliferation in kidneys of rat (73). Since there is no NOAEL, a safety 
factor of 3x was added to the 100x uncertainty factor (safety margin of 300) to establish a 
reference dose of 0.583 mg/kg/d for chlorothalonil (73).  
3.6.4.1 Dosimetry 
 
The USEPA has established a dermal penetration rate of 0.15% for chlorothalonil (CHT RED). 
Using the dosimetry residues of 10,241 (±3042) µg, an absorbed dermal dose of 15.4 µg 
chlorothalonil is calculated. An average of 28.9 µg chlorothalonil was recovered from the air 
samplers for a total absorbed dose of 44.3 µg. We divide this by 80 kg to get a daily 
absorbed dose of 0.55 (±0.04), µg/kg/d for chlorothalonil (Eqn. 22). 
Eqn. 25                       44.3 𝜇𝑔 (± 4.57) ÷ 80𝑘𝑔 = 0.55 (± 0.16) 𝜇𝑔/𝑘𝑔/d 
 
HQ 
We divide the dose by the reference dose to get our hazard quotient for chlorothalonil (Eqn. 
26): 
Eqn. 26                   HQ = 0.55 (±0.04)µ𝑔/𝑘𝑔/𝑑 ÷ 583 µ𝑔/𝑘𝑔/𝑑 = 𝟎. 𝟎𝟎𝟎𝟗 
MOE 
To calculate the MOE, we divide the LOAEL in this case by the absorbed dose: 
 
Eqn. 27                                   MOE =175000 µ𝑔/𝑘𝑔/𝑑 ÷ 0.55(±0.07) µ𝑔/𝑘𝑔/𝑑 = 318182 
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3.6.4.2 Biomonitoring 
     The lack of pharmacokinetic data precludes us from deriving HQs and MOEs for 
chlorothalonil from the biomonitoring data. 
3.6.5 Cyfluthrin Risk Assessment 
     The USEPA has established a short term dermal NOAEL of 2.5 mg/kg/d based on gait 
abnormalities, increased evidence of vomiting, and suggestive decreased body weight gain in 
dogs (74). Using an uncertainty factor of 100 and an FQPA SF of 1, a RfD of 0.02 mg/kg/d was 
established (74). 
3.6.5.1 Dosimetry 
 
     The USEPA has established a dermal penetration rate of 5% for cyfluthrin (74). Using this 
5% dermal penetration factor and the 83.9 (± 17.8) μg determined from the dosimetry 
residues gives us an absorbed dermal dose of 4.2 µg. All air samplers were negative for 
cyfluthrin, so ½ of the detection limit (0.05 µg cyfluthrin) was assumed as an inhaled dose, 
for a total absorbed dose of 4.25 (±0.40) µg. Dividing by 80 kg, we get a dose of 0.053 
(±0.40) µg/kg/d for cyfluthrin (Eqn. 28). 
Eqn. 28                    4.2 𝜇𝑔 (± 0.89) ÷ 80𝑘𝑔 = 0.053 (± 0.011) 𝜇𝑔/𝑘𝑔/d 
 
HQ 
We divide the dose by the reference dose to get our hazard quotient for cyfluthrin (Eqn. 29): 
 
Eqn. 29                        HQ = 0.053 (±0.40) µ𝑔/𝑘𝑔/𝑑 ÷ 20 µ𝑔/𝑘𝑔/𝑑 = 𝟎. 𝟎𝟎𝟐𝟕 
 
MOE 
To calculate the MOE, we divide the NOAEL by the absorbed dose: 
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Eqn. 30         MOE = 2500 µ𝑔/𝑘𝑔/𝑑 ÷ 0.053 (±0.40) µ𝑔/𝑘𝑔/𝑑 = 47,170 
 
3.6.5.2 Biomonitoring 
     All urine samples were negative for cyfluthrin. We therefore calculate HQs and MOEs using 
the detection limit of 4.0 µg. Dividing this by 80 kg results in a dose of 0.05 µg/kg/d. We 
determine the HQs and MOEs as done for carfentrazone-ethyl above: 
HQ 
We divide the estimated acquired dose by the reference dose to get our hazard quotient for 
carfentrazone-ethyl (Eqn. 31): 
Eqn. 31                                HQ = 0.05 µ𝑔/𝑘𝑔/𝑑 ÷ 20 µ𝑔/𝑘𝑔/𝑑 = 𝟎. 𝟎𝟎𝟐𝟓 
 
MOE 
 To calculate the MOE, we divide the NOAEL by the absorbed dose (Eqn. 32): 
 
Eqn. 32                      MOE =2500  µ𝑔/𝑘𝑔/𝑑  ÷  0.05 µ𝑔/𝑘𝑔/𝑑 = 50,000 
 
3.6.6 2,4-D Risk Assessment 
     The USEPA acute dietary NOAEL and RfD for the general population (including infants and 
children) were used for risk assessment of 2,4-D. No dermal data are available because adverse 
effects were not observed at any dose (75). The NOAEL was 67 mg/kg/d (slightly altered gate), 
and the RfD was 0.67 mg/kg/d. The RfD was derived by dividing the NOAEL by 10 for the 
uncertainty factor (UFA, interspecies differences) and another 10 for UFH (potential intraspecies 
variation) (75). There was no modification to the NOAEL made based on the FQPA SF. The HQ 
and MOE are given below: 
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3.6.6.1 Dosimetry 
The inhaled dose of 2,4-D was estimated at 0.0005 µg. 100% uptake is assumed with the inhaled 
dose. The average amount of 2,4-D recovered from the dosimeters was 332 (± 130.8) µg. A 10% 
dermal penetration rate was assumed for 2,4-D according to the USEPA (76). We can therefore 
assume a dose of 33.2005 µg 2,4-D. Dividing the daily dose by 80 kg (Exposure Factors 
Handbook) yields the dose in µg/kg/d (Eqn 1R) acquired by dosimetry (Eqn. 33). 
Eqn. 33                    33.2005 (±13.1) 𝜇𝑔 ÷ 80𝑘𝑔 = 0.415 (±0.16) 𝜇𝑔 /𝑘𝑔/d 
 
HQ 
We then divide the acquired dose by the reference dose to get our hazard quotient for 2,4-D 
(Eqn. 34): 
 
Eqn. 34                     HQ = 0.415 (±0.14)µ𝑔/𝑘𝑔/𝑑 ÷ 670 µ𝑔/𝑘𝑔/𝑑 = 𝟎. 𝟎𝟎𝟎𝟔𝟐 
 
MOE 
To calculate the MOE, we divide the NOAEL by the absorbed dose: 
 
Eqn. 35                    MOE = 67,000 µ𝑔/𝑘𝑔/𝑑 ÷ 0.415 (±0.14)µ𝑔/𝑘𝑔/𝑑 = 161,446 
 
3.6.6.2 Biomonitoring 
     We can also calculate HQs and MOEs from the biomonitoring data where the absorbed dose 
was 0.274 (±0.12) µg/kg/d: 
HQ 
We divide the absorbed dose by the reference dose to get our hazard quotient for 2,4-D (Eqn 
36): 
Eqn. 36                       HQ = 0.274 (±0.12) µ𝑔/𝑘𝑔/𝑑 ÷ 670 µ𝑔/𝑘𝑔/𝑑 = 𝟎. 𝟎𝟎𝟎𝟒1 
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MOE 
 To calculate the MOE, we again divide the NOAEL by the absorbed dose (Eqn. 37): 
 
Eqn. 37                         MOE =67,000µ𝑔/𝑘𝑔/𝑑 ÷ 0.274  (±0.12) µ𝑔/𝑘𝑔/𝑑 = 244,526 
 
3.6.7 Halofenozide Risk Assessment 
     Neither an acute NOAEL or LOAEL has been established for halofenozide, and the USEPA has 
not established a reference dose for this compound. Murphy and Haith (77) used a chronic 
NOAEL of 3.8 mg/kg/d and a chronic reference dose of 0.038 mg/kg/d.  Additionally, there is no 
established dermal penetration rate for halofenozide, no pharmacokinetic data and metabolite 
standard are not available. This lack of data is due to the fact that halofenozide was put on the 
market rather quickly as a reduced risk pesticide, and just as quickly had its registration 
voluntarily removed. Using the calculation from Murphy and Haith (77), we can calculate chronic 
HQs and MOEs. 
3.6.7.1 Dosimetry 
 Since there is no biomonitoring data for halofenozide, the calculations are made with only 
dosimetry data. The USEPA has not established the dermal penetration rate for halofenozide, so 
a default penetration value of 20% was chosen. Most pesticides have a dermal absorption rate 
between 2-20% (78), so we have selected to use the top end of this range. Using the 944 (±249) 
μg determined on the dosimeters, this 20% penetration rate gives us an absorbed dermal dose 
of 188.8 µg. The halofenozide air samplers contained 0.14 µg, giving us a combined dose of 
188.9 µg. We divide this by 80 kg to get our dose of 2.36 (±0.62) µg/kg/d (Eqn. 38). 
Eqn. 38  188.9 (±49.9) 𝜇𝑔 ÷ 80𝑘𝑔 = 2.36 (±0.62) 𝜇𝑔 /𝑘𝑔/d 
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Chronic HQ 
We divide the estimated acquired dose by the reference dose to get our hazard quotient for 
halofenozide (Eqn 39):  
 
Eqn. 39                             HQ = 2.36 (±0.36) µ𝑔/𝑘𝑔/𝑑 ÷ 38 µ𝑔/𝑘𝑔/𝑑 = 𝟎. 𝟎𝟔𝟐 
 
Chronic MOE 
To calculate the MOE, we divide the NOAEL in this case by the absorbed dose: 
 
Eqn. 40                         MOE = 3800 µ𝑔/𝑘𝑔/𝑑 ÷ 2.36 (±0.36) µ𝑔/𝑘𝑔/𝑑 = 1610 
 
3.6.7.2 Biomonitoring 
     The lack of pharmacokinetic data and available metabolite standards preclude us from 
deriving HQs and MOEs for halofenozide through biomonitoring. 
 
3.6.8 Imidacloprid Risk Assessment 
     The USEPA acute dietary NOAEL and RfD for the general population were used for risk 
assessment of imidacloprid. No dermal data are available because adverse effects were not 
observed at any dose (79).  The NOAEL was 42 mg/kg/d (decreased motor and locomotor 
activity, female rats, 59), and the RfD is 0.14 mg/kg/d. The RfD is derived by multiplying the 
NOAEL by 10 for the uncertainty factor (UFA, interspecies differences) and another 10 for UFH 
(potential intraspecies variation), and an FQPA SF of 3 
3.6.8.1 Dosimetry 
     Imidacloprid was not detected on any of the air samplers, so we assume the dose to be 
0.0026 µg, based on ½ of the limit of detection. The average amount of imidacloprid recovered 
from the dosimeters was 3.15 (± 1.47) µg. A 7.2% dermal penetration rate is assumed for 
imidacloprid according to the USEPA (79) giving us an absorbed dermal dose of 0.23 (± 0.11) µg. 
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We can therefore assume a total absorbed dose of 0.2326 (± 0.11) µg imidacloprid. We then 
divide the dose by 80 kg (68) to get our imidacloprid dose in µg/kg/d (Eqn 38) 
Eqn. 41                     0. 2326 (± 0.11)𝜇𝑔 ÷ 80𝑘𝑔 = 0.0029 (± 0.0014) 𝜇𝑔/𝑘𝑔/d 
 
HQ 
We then divide the acquired dose by the reference dose to get our hazard quotient for 
imidacloprid (Eqn. 42): 
Eqn. 42                    HQ = 0.0029 (± 0.0014) µ𝑔/𝑘𝑔/𝑑 ÷ 140 µ𝑔/𝑘𝑔/𝑑 = 𝟎. 𝟎𝟎𝟎𝟎𝟐 
 
MOE 
To calculate the MOE, we simply divide the NOAEL by the absorbed dose: 
 
Eqn. 43                 MOE = 42,000 µ𝑔/𝑘𝑔)/𝑑 ÷ 0.0029 (± 0.0006) µ𝑔/𝑘𝑔/𝑑 = 14,482,275 
 
3.6.8.2 Biomonitoring 
     Imidacloprid was not detected in any urine samples, so we estimate the dose at the detection 
limit (10 µg), and divide by 80 kg, resulting in a dose of 0.125 µg/kg/d. We determine the HQs 
and MOEs as we did for carfentrazone-ethyl and cyfluthrin above. 
HQ 
We divide estimated acquired dose by the reference dose to get our hazard quotient for 
imidacloprid (Eqn. 44): 
Eqn. 44                            HQ = 0.125 µ𝑔/𝑘𝑔/𝑑 ÷ 140 µ𝑔/𝑘𝑔/𝑑 = 𝟎. 𝟎𝟎𝟎𝟗 
 
MOE 
 To calculate the MOE, we again divide the NOAEL by the absorbed dose (Eqn. 45): 
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Eqn. 45                    MOE =42,000 µ𝑔/𝑘𝑔/𝑑 ÷ 0.125 µ𝑔/𝑘𝑔/𝑑 = 336,000 
 
3.6.9 MCPP-p Risk Assessment 
     We used the USEPA acute dietary NOAEL and RfD for the general population to assess the risk 
of MCPP-p. No dermal data are available because adverse effects were not observed at any dose 
(80).  The NOAEL was 175 mg/kg/d (closed eyelids, prone body position, hypoactivity, ataxia, 
decreased number of rearings in females, increased foot landing splay in males, and decreased 
motor activity), and the RfD is 1.75 mg/kg/d (80). The RfD is derived by multiplying the NOAEL 
by an uncertainty factor of 100. The HQ and MOE are given below: 
3.6.9.1 Dosimetry 
     The inhaled dose of MCPP-p is estimated at 0.0034 µg. The average amount of MCPP-p 
recovered from the dosimeters was 772 (± 277) μg. The USEPA has no accepted dermal 
penetration factor, but the European Commission Health and Consumer Protection Directorate 
has accepted a 10% dermal penetration rate (72). We can therefore assume a dose of 77.2034 
(± 27.7) µg MCPP-p. We then divide the dose by 80 kg (68) to get our dose in µg/kg/d (Eqn. 46) 
Eqn. 46                      77.2034 (±27.7)𝜇𝑔 ÷ 80𝑘𝑔 = 0.97(±0.35) 𝜇𝑔 /𝑘𝑔/d 
 
HQ 
We divide this by the reference dose to get our hazard quotient for MCPP-p (Eqn. 44): 
 
Eqn. 47                     HQ = 0.97 (±0.35) µ𝑔/𝑘𝑔/𝑑 ÷ 1750 µ𝑔/𝑘𝑔/𝑑 = 𝟎. 𝟎𝟎𝟎𝟓𝟓 
 
MOE 
To calculate the MOE, we divide the NOAEL by the absorbed dose: 
 
Eqn. 48                                MOE = 175,000 µ𝑔/𝑘𝑔/𝑑 ÷ 0.97 µ𝑔/𝑘𝑔/𝑑 = 180,412 
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3.6.9.2 Biomonitoring 
     We can also calculate HQs and MOEs from the biomonitoring data where the absorbed dose 
was 1.27 µg/kg/d: 
HQ 
We divide this by the reference dose to get our hazard quotient for MCPP-p (Eqn 49): 
 
Eqn. 49                          HQ = 1.27 µ𝑔/𝑘𝑔/𝑑 ÷ 1750 µ𝑔/𝑘𝑔/𝑑 = 𝟎. 𝟎𝟎𝟎𝟕𝟑 
 
MOE 
 To calculate the MOE, the NOAEL divided by the absorbed dose (Eqn. 50): 
 
Eqn. 50                         MOE =175,000 µ𝑔/𝑘𝑔/𝑑 ÷ 1.27  µ𝑔/𝑘𝑔/𝑑 = 137,795 
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CHAPTER 4 
 DISCUSSION 
     Golfer exposure estimates generated by this study used a 1-hour re-entry interval following 
full course, maximum rate applications and worst case exposure scenarios. The exposure 
scenario can be considered worst case based on the following: 
• Maximum application rates were used. 
• Play commenced 1 hour post-application or post-irrigation. 
• The entire course was treated (tees, greens and fairways are not usually treated 
concurrently). 
• Golfers spent the entire 4 hours on treated turf (golfers are in untreated areas between 
holes during actual play). 
4.1 DFR 
     Table 15 shows the amount of pesticide transferred to the DFR sample as a percent of the 
amount of pesticide applied to the turf.  The use of post application irrigation reduced the 
percent of available pesticide ~9-fold (30-fold when halofenozide is not included). Post-
application irrigation most likely moves even water insoluble pesticides into the thatch and soil, 
where it is not available for golfer exposure. In the one instance where we can directly compare 
the effects of irrigation on the percent of applied pesticide available, irrigation reduced DFR 
residues of cyfluthrin ~20-fold, despite the relative insolubility of cyfluthrin in water (0.0019 
mg/L). 
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Table 15. Percent of applied pesticide (with coefficient of variance) recovered from DFR in order 
of increasing availability. 
 
Without Post-Application Irrigation With Post-Application Irrigation 
Pesticide Percent Available Pesticide Percent Available 
Carfentrazone-ethyl 0.11% (2.8%)  Imidacloprid 0.057% (60.0%) 
Azoxystrobin 0.53% (4.0%)   
Chlorothalonil 1.3% (87.2%)   
Cyfluthrin 1.7% (70.0%) *Cyfluthrin 0.089% (NA) 
MCPP 3.6% (100.0%) Halofenozide 0.598% (19.1%) 
2,4-D 5.7% (86.2%)   
  MEAN w/ 
halofenozide 
0.25% 
MEAN 2.2% MEAN w/o 
halofenozide 
0.073% 
*Data from research conducted at the same site using identical protocols. 
 
   Without post application irrigation, the most water soluble pesticides (MCPP = 860 mg/L, and 
2,4-D = 23,180 mg/L) showed the greatest available residues. The available residue levels from 
the remaining pesticides that received no post-application irrigation showed no clear pattern 
with respect to their water solubilities. This result may be due to the fact that their range of 
water solubilities is too narrow (0.0019 mg/L for cyfluthrin to 12 mg/l for carfentrazone-ethyl). 
For pesticides that received post-application irrigation, the more water soluble imidacloprid 
(610 mg/L water solubility) had lower percent available residues than the relatively insoluble 
cyfluthrin (0.0019 mg/L) or the relatively more water soluble halofenozide (12.3 mg/L), though 
the difference between imidacloprid and cyfluthrin is not significant. 
     Available pesticide residues typically declined rapidly over the first few hours of the 
experiment. With pesticides that received no post-application irrigation and had 0.25-hour post-
application data, the DFR levels declined 37%, 43%, 50%, and 55% for carfentrazone-ethyl, 
azoxystrobin, chlorothalonil, and cyfluthrin, respectively, between 0.25-hour and 1 hour post-
application. Of the pesticides that received post-application irrigation and have 0.25-hour post-
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application data, imidacloprid DFR declined 4.3-fold between 0.25-hour and 1 hour post-
application, while halofenozide residues did not decline at all. In the case of imidacloprid, post-
application irrigation appears to have resulted in a greater reduction of DFR than the highly 
consistent results obtained from those pesticides that received no post-application irrigation. 
The results from halofenozide indicate that this phenomenon is not universal.  
     A similar dissipation pattern was found between hours 1 and 2. Most pesticides that did not 
receive post-application irrigation showed between a 23% (carfentrazone-ethyl) and 61% 
(MCPP-p) reduction in available residues over this time interval. The one exception was 
chlorothalonil, which had a 2.4-fold reduction during this time period. This result may be due to 
the extremely high application rate used for this compound.  Conversely, most pesticides that 
received post-application irrigation had a much greater reduction during this time period. 
Imidacloprid DFR declined 14-fold and halofenozide residues declined 5.9-fold. The exception in 
this case is cyfluthrin, where residues declined only 70% between hours 1 and 2. Cyfluthrin is far 
less water soluble than imidacloprid or halofenozide, and more cyfluthrin residues may have 
remained on the surface of turfgrass leaf and the thatch where it is available for transfer to the 
hand, ankle and lower leg of the golfer. 
     Regardless of post-application irrigation, DFR of most of the test pesticides declined between 
4.6-fold (cyfluthrin with irrigation) and 25.8-fold (MCPP-p) between hours 1 and 5, the period of 
play of simulated golf. The exception in this case is carfentrazone-ethyl, where DFR declined 
only 50% over this time period. This reduced loss may be due to the extremely low application 
rate of this herbicide. 
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4.2 Re-entry Interval 
     There is currently no re-entry interval following pesticide applications to golf courses. 
Therefore, golfers could commence play immediately following an application. If this occurs, 
exposure will be greater than that estimated using the mean DFR level calculated from 1-5 hr, 
the time during which the play of simulated golf occurred. We can estimate exposure from this 
scenario using our 0.25 hour DFR samples and our experimentally derived transfer factor. 
Imidacloprid DFR declined rapidly (4.3-fold) between hours 0.25 and 1, and this may be due to 
the post-application irrigation. Compounds that did not receive irrigation declined more slowly, 
between 37% and 55% during this time period. Calculating a DFR for imidacloprid between 
hours 0.25 and 2 results in an average DFR of 0.0013 (± 0.00015) µg/cm2, 2.6-fold greater than 
that found for imidacloprid DFR from hours 1-5 (0.0005 µg/cm2). Using the transfer factor 
derived from our experiments, we can estimate a dermal dose of 4.7 µg, 2.6-fold higher than the 
dermal exposure determined between hours 1-5. Since golfer exposure to imidacloprid is almost 
exclusively through the dermal route, the HQ would increase 2.6-fold, from 0.000016 to 
0.00004, and the MOE would decrease 2.6-fold from 18,760,870 to 7,215,719. Although these 
levels are not approaching a level of concern, golfers will receive a higher dose than with a 1-
hour re-entry period. 
4.3 Effect of Irrigation 
     Pesticides that received no post-application irrigation declined much less over hours 0.25-1. 
Carfentrazone-ethyl (37%), azoxystrobin (43%), chlorothalonil (50%), and cyfluthrin (55%) all had 
slower declines than imidacloprid. We can estimate the dose solely from the dermal data 
because azoxystrobin, carfentrazone-ethyl, and cyfluthrin were never detected in the air 
samplers, and inhalation exposure contributed at most 2% (cyfluthrin) to the total dose. 
Estimating dermal dose for carfentrazone-ethyl from hours 0.25-2 results in a dermal exposure 
95 
 
of 4.2 (±0.06) µg, 66.6% higher than the dermal dose of carfentrazone-ethyl from hours 1-5 (2.8 
(±0.7) µg). This would increase the hazard quotient from 0.0000008 for hours 1-5 to 0.0000013 
for hours 0.25-5, and decrease the MOE from 125,000,000 to 8,337,500. Although these levels 
are not approaching a level of concern, golfers will receive a higher dose than with a 1-hour re-
entry period. 
     Calculating the dermal exposure from azoxystrobin over hours 0.25-2 results in a dermal dose 
of 1890 (± 71.8) µg, 2.3-fold higher than the dose determined between hours 1-5. This would 
increase the HQ from 0.0006 for hours 1-5 to 0.001 for hours 0.25-2, and decrease the MOE 
from 500,000 to 217,391 over the same time period. 
    We cannot estimate a dose for chlorothalonil from hours 0.25-2, because 65% of the dose was 
from airborne residues, and we have no air concentration data from hours 0.25-1. 
     Dermal exposure to cyfluthrin would increase 3.1-fold, from 83.9 (± 8.0) μg for hours 1-5 to 
257.9 (± 62.7) μg for hours 0.25-2. This increase would lead to an increase in the HQ from 
0.0027 for hours 1-5 to 0.08, and decrease the MOE from 47,170 for hours 1-5 to 15,723 for 
hours 0.25-2. 
     While none of these HQs and MOEs approach levels of concern as determined above at 
shorter re-entry times, a 1-hour re-entry interval can reduce exposure as much as 3-fold 
(cyfluthrin), minimizing exposure to golfers 
     There is one confounding factor when comparing data from pesticides that received post-
application irrigation to those that did not. Watering the compounds in took approximately 1 
hour, so sampling under these conditions started 1 hour and 0.25-hour after the completion of 
the application. In some sense, hours 1-2 for compounds that received post-application 
irrigation is comparable to hours 2-3 for those that did not, since hour 1 samples were taken 2 
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hours after application when pesticides were watered in. It is clear the residues decline rapidly 
between hours 2-5, and this may explain part of the larger reductions seen between hours 0.25 
and 1, and hours 1-2 for those compounds that received post-application irrigation.      
4.4 Dosimetry 
     While the dermal exposure estimates were based on the residues from the entire suit, 88.6% 
of the 2,4-D residues and 90.6% of the MCPPP-p residues were found on the hands, upper sock 
and lower leg, regions that were left exposed by our biomonitoring group and are typically left 
exposed by golfers. Thus, the majority of the dermal exposure was to areas left unprotected by 
clothing.  This situation allows us to determine the dermal dose without considering the effect 
of clothing on dermal absorption. 
     Dermal absorption is a complicated process that is influenced by many factors such as the 
thickness of the stratum corneum layer and various skin appendages (Hair follicles, sebaceous 
glands, sweat glands and their differential distribution on various body regions (81,82). Dermal 
absorption also varies between individuals, usually attributed to genetics, age and health (83). 
The concentration of pesticides on the skin and the inert ingredients in a pesticide formulation 
can also affect penetration. Dermal penetration of carbaryl was shown to be increased by 
sodium lauryl sulfate, piperonyl butoxide, and 1-napthol. Interestingly, DEET increased dermal 
penetration of carbaryl when the vehicle was acetone, but not DMSO (84). Mild damage to the 
skin (85), occlusion through clothing or the use of an ointment such as sunscreen (86) and 
increased skin hydration (87), have all been shown to increase dermal penetration of pesticides. 
Increased temperature, whether through occlusion or ambient conditions, can also increase 
dermal penetration (88,89). The lipid structure is altered in skin at temperatures as low as 40°C, 
with higher temperatures leading to lipid and protein denaturation (90). Despite all the 
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variability inherent in using dosimetry to assess dermal exposure, it is the best available 
technique when biomonitoring is not practical. 
     The use of post-application irrigation did not drastically affect the distribution of residues on 
the dosimeter and therefore the regions of the body receiving the dermal exposure. 
Carfentrazone-ethyl residues on the gloves and upper sock (the only regions with detectable 
residues) are artificially low. All other segments were assigned a value of ½ of the detection 
limit, causing the glove and upper sock segments to appear to contain a lower percentage of the 
residues. Because of this, I have excluded carfentrazone-ethyl from the following calculation. 
Compounds (Azoxystrobin, chlorothalonil, cyfluthrin, 2,4-D, MCPP-p) that received no post 
application irrigation had an average of 58.5% (± 10.3) of the total dermal residues on the hand, 
and 30.7% (± 9.9) on the upper sock and lower leg. Of the compounds that did receive post-
application irrigation, imidacloprid glove samples contained 48.6% (± 9.3) of the residues, while 
the lower leg and upper sock had 43.6% (± 6.4). These values are close to the values found for 
the pesticides that did not receive post-application irrigation. Previous research (48) found that 
with chlorpyrifos and carbaryl, the majority of the dosimetry residues were on the lower leg and 
upper sock (28-50%) when post-application irrigation was used, with a much lower percentage 
on the hand (8-15%). The amounts found on the sock and lower leg are consistent with the 
findings of this research, but the percentage found on the hands is much higher in the current 
study. Residues on the upper sock and lower leg are most likely due to water and associated 
pesticides in the turf being kicked up on the ankle/calf through walking. Contamination of the 
hands is most likely through direct contact. Simulated golf commenced at 8:00 AM each day. At 
this time, there were heavy dews on the turf. The microclimate of the research facility, between 
a large river and a small mountain, contributed to this with frequent morning fogs. This 
increased water on the turf may have facilitated the greater transfer to the hands by allowing 
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pesticides on the surface of the plant to be in solution. It is also possible that the hands of the 
volunteers were wet because of the dew on the turf surface, and wet hands have been shown to 
increase the transfer of pesticides from turf 2-3-fold (91). 
4.5 Airborne residues 
     The pesticides studied in this work all had fairly low volatility. Research by Putnam et al. (11) 
showed that in the case of chlorpyrifos, a relatively volatile insecticide, approximately 1/3 the 
absorbed dose came through inhalation exposure. In the intervening years, most volatile 
pesticides have been removed from use on golf courses. The inhaled dose was assumed to have 
100% absorption, but it is unlikely these non-volatile compounds were inhaled in the vapor 
phase. It is more likely that they were sorbed to dust and particles and were likely swallowed 
after being trapped in the mucus, like an oral exposure. It is still prudent, nonetheless, to treat 
the dose like an inhaled dose. The inhaled dose from 2,4-D was estimated at 0.0005 µg (1/2 
LOD), less than 0.002% of the 33.2 dermal dose, and the MCPP-p inhaled dose was calculated at 
0.0034 µg, 0.004% of the 77.2 µg dermal dose. Thus, the inhaled doses contributed only a small 
portion of the overall dose with these low-volatility pesticides. Using data from air samplers 
with positive detections (chlorothalonil, 2,4-D, halofenozide, MCPP-p), the percentage of the 
dose contributed through inhalation ranged from 0.002% (2,4-D) to 0.07% for halofenozide, 
contributing very little to the overall dose. No pesticides were recovered from the air samplers 
for azoxystrobin, carfentrazone-ethyl, cyfluthrin or imidacloprid. The estimated inhaled dose of 
these compounds using half the limit of detection constituted 0.0007% (azoxystrobin) to 1.4% 
(imidacloprid) of the total dose. In all cases, inhalation exposure contributed less than 1.5% of 
the dose. 
     In the case of chlorothalonil, the inhaled dose constituted 65% of the total absorbed dose. 
This finding is primarily due to the extremely low dermal penetration rate of chlorothalonil 
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(0.15%). Though the amount of chlorothalonil found on the dosimeters was quite high, 10,241 
μg (±788 μg), the estimated dermal dose was only 15.4 µg. Although it is likely that the inhaled 
dose of the non-volatile chlorothalonil (28.9 µg) was principally through its sorption to dust 
particles or as an aerosol, it is still prudent to treat it as an inhaled dose.  
4.6 Transfer Factors 
     Transfer factors (TF) relate the amount of pesticide found on the DFR to that found on the 
dosimeter. A larger TF indicates more of the residue is transferred from the turf to the golfer. 
Transfer factors ranged from a low of 680 (± 358) for 2,4-D to a high of 2207(± 341) for 
halofenozide, a 3.2-fold difference. They do not seem to be correlated with any physical 
property of the pesticide, such as water solubility or Kow. Given the large degree of differences in 
molecular weights, chemical structures, water solubilities, and Kow, the 3.5-fold difference 
determined for the TFs of the test pesticides is relative small. One approach would be to use a 
TF generated in this study and apply it across a chemical class of pesticides. For example, we 
could choose to use the 2,4-D TF of 1482 (± 307) cm2/hr) for all phenoxy acid herbicides. This 
value is very close to the TF of 1462 (± 263) cm2/hr) calculated for MCPP-p, the other phenoxy 
acid herbicide in this study. This finding indicates that it may be appropriate to use this TF across 
this entire class of herbicides. We could similarly use imidacloprid for the neonicotinoid 
insecticides, azoxystrobin for the strobilurin fungicides, halofenozide for the diacylhydrazine 
insecticides and cyfluthrin for the pyrethroid insecticides.  In cases where there is no TF for a 
class of pesticides, it seems prudent to select the highest transfer factor in our study 
(halofenozide, 2207) to provide the greatest margin of safety, though this would most likely 
overestimate the exposure from certain compounds. In this way, we would only have to use 
easily obtained and inexpensive DFR samples, apply our chosen TF and calculate a dermal dose. 
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Since the vast majority of our dose is dermal (aside from chlorothalonil and its high application 
rate), this approach appears to be an appropriate way to estimate exposure. 
4.7 Biomonitoring 
     The biomonitoring doses calculated from samples where the analytes were not detected in 
the urine (carfentrazone-ethyl, cyfluthrin, and imidacloprid) do not allow us to establish an 
actual dose. Therefore, we estimated the dose in these cases as the LOD and determined a HQ 
by dividing the LOD by the RfD and then reporting the HQ as some number less that the 
estimated HQ. The HQ for carfentrazone-ethyl is <0.00009, for cyfluthrin <0.0025 and for 
imidacloprid <0.0009. All these estimated HQ’s are well below 1.0, indicating little concern from 
these exposures. To calculate the MOE we divide the NOAEL by the LOD, and report the MOE as 
some number > the estimated MOE. The MOE for carfentrazone-ethyl is > 11,166,667, for 
cyfluthrin >50,000 and for imidacloprid >336,000. All these estimated MOE’s are well above the 
EPA level of concern. Biomonitoring for 2,4-D and MCPP-p is discussed below. 
4.8 Dosimetry vs Biomonitoring 
     The most relevant data sets to compare the results obtained from dosimetry versus 
biomonitoring is with the data generated by exposures to 2,4-D and MCPP-p. All other pesticides 
analyzed from the biomonitoring group (carfentrazone-ethyl, cyfluthrin and imidacloprid) were 
below the limit of detection, so we cannot directly compare doses.   
     Using the USEPA dermal exposure rate of 10% for 2,4-D, we estimated an absorbed dose of 
0.42 µg/kg/d. This amount is significantly greater (1.56-fold, unpaired t-test; p < 0.05) than the 
dose estimated by biomonitoring (0.27 ±0.121 µg/kg/d). It is important to note that the USEPA 
estimation of dermal penetration is often meant to be protective of public health, and does not 
necessarily represent the scientific consensus on the issue.  
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     A meta-analysis of dermal penetration studies in humans by Rossa et al. (92) determined a 
weighted average dermal penetration rate of 5.7%. The areas assessed for dermal penetration 
in that study (palm, back of hand, forearm) were the areas receiving most of the dose in our 
study (66% for 2,4-D and 72% for MCPP-p). The bulk of the rest of the dose was found on the 
upper sock and lower leg (25% 2,4-D, 20% MCPP-p). These regions of skin have some similarity 
to the forearm, with dermal penetration at the ankle 1.2-fold greater than that of the forearm 
(93). Using the dermal penetration rate of 5.7% yields an estimated dose of 0.23 (±0.092 
µg/kg/d) from dosimetry. This dose is not statistically different from the estimated dose 
established by biomonitoring (0.27 ±0.121 µg/kg/d, unpaired t-test; p > 0.05).  
         The estimated dose determined for MCPP-p by dosimetry was 0.97 µg/kg/d (±0.34) using 
the 10% dermal penetration rate (72). MCPP-p exposure from biomonitoring was estimated at 
1.26 µg/kg/d (±0.84). Exposure estimates for MCPP-p using the 10% dermal penetration rate 
are not significantly different from those established through biomonitoring (unpaired t-test; p > 
0.05).  
Using the 5.7% dermal penetration rate used for 2,4-D above, the estimated dermal dose of 
MCPP-p was 0.54 µg/kg/d. The exposure estimate for MCPP-p from the dosimetry data using 
the 5.7% dermal penetration rate was significantly different from that derived by biomonitoring 
(unpaired t-test; p < 0.05). It seems likely that the dermal penetration rate of MCPP-p is closer to 
10% than 5.7%.   
     The agreement between the dosimetry and biomonitoring data provides validation for the 
use of dosimetry in cases where biomonitoring is impractical.  
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4.9 Risk Assessment 
     All pesticides tested resulted in Hazard Quotients (HQ) and Margins of Exposure (MOE) that 
indicate minimal hazard from the worst-case golfer exposure scenarios used in this study. 
Excluding halofenozide, hazard quotients determined from dosimetry ranged from 0.0027 
(cyfluthrin) to 0.0000008 for carfentrazone-ethyl. MOEs ranged from 47,170 for cyfluthrin to 
125,000,000 for carfentrazone-ethyl based on dosimetry. Since no acute toxicological data was 
available for halofenozide, chronic NOAELs were used. This procedure resulted in a chronic HQ 
of 0.62, and a MOE of 1610. These hazard estimates do not indicate a high level of concern, 
however, they are orders of magnitude greater than the others, primarily due to the use of a 
chronic NOAEL. The fact that halofenozide is no longer being used means future exposures are 
unlikely. 
     The USEPA now uses MOE to assess risk in conjunction with the previously used HQ. The two 
methodologies use the same information (LOAEL or NOAEL, uncertainty factors) but apply them 
differently. They essentially have an inverse relationship, where a high MOE (>100-300) 
indicates limited concern from an exposure, and a low HQ (<1) means the same.  
     The HQ is the dose of a pesticide divided by the reference dose (RfD). The RfD is usually a 
NOAEL (sometimes a LOAEL) divided by ten-fold uncertainty factors (UF). Usually, two UF are 
used UFA for interspecies differences and UFH for potential intraspecies variation. There is 
sometimes a modification to the NOAEL based on the Food Quality Protection Act Safety Factor 
(FQPA SF), which protects infants and children if the data in the study is deemed incomplete, or 
LOAELs are being used. Since the uncertainty is incorporated into the RfD, any HQ > 1.0 
(acquired dose is > RfD) indicates concern with an exposure. It does not mean that adverse 
effects will occur, only that the absence of adverse effects is less certain.  
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     The margin of exposure is the inverse of the HQ. It is the NOAEL (or LOAEL) divided by the 
dose. The uncertainty factors are incorporated when establishing a level of concern (LOC). For 
most of our test pesticides, we only accounted for UFA and UFB, so the LOC is 100, meaning any 
MOE approaching 100 is cause for concern. If an FQPA SF of 3 is used in establishing the RfD 
(azoxystrobin, chlorothalonil, imidacloprid) then the LOC is 300. In practice, any MOE < 1000 
starts to raise concerns. 
4.10 Reduced Risk Pesticides 
     Reduced risk pesticides are classified by the EPA as those that have a low impact on human 
health, non-target organisms (fish, birds, bees), low potential for groundwater contamination, 
lower use rates and new modes of action. Carfentrazone-ethyl (herbicide), azoxystrobin 
(fungicide) and halofenozide (insecticide) are all classified as reduced risk pesticides, though 
halofenozide is no longer in use. Comparing the hazard associated with these compounds to 
conventional herbicides 2,4-D and MCPP-p, the fungicide chlorothalonil, and the insecticides 
imidacloprid and cyfluthrin will allow us to determine if reduced risk pesticides mitigate hazard 
in our golfing scenario. 
     The use of the chronic reference dose for halofenozide makes it impossible to compare the 
MOE with other compounds where reference doses were derived from acute toxicity studies.  
    Carfentrazone-ethyl had a MOE 774-fold greater than 2,4-D, and 686-fold higher than MCPP-
p, indicating an increased margin of safety over these conventional pesticides based on 
dosimetry. Azoxystrobin had a MOE 2.7-fold higher than chlorothalonil, as determined by 
dosimetry, again indicating an increased margin of safety. Unfortunately, a direct comparison of 
these reduced risk pesticides to older conventional compounds using biomonitoring is 
impossible. Much of this is due to the characteristics that make these pesticides reduced risk, 
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such as a low use rate (low exposure) and diverse and facile mammalian metabolism. There is 
often a wide range of metabolites in mammals, with no single one sufficiently abundant for a 
low detection limit. Nonetheless, in previous studies at the same site using the same protocols, 
HQs were determined for the insecticides, chlorpyrifos (0.032) and carbaryl (0.015), using 
biomonitoring. These HQs are 1-5 orders of magnitude greater than those generated from the 
insecticides evaluated here by biomonitoring approaches (cyfluthrin HQ = 0.0027, imidacloprid 
HQ = 0.000016). Therefore, the use of more selective modern pesticides can reduce golfer 
exposure through lower use rates of these compounds compared to conventional pesticides, 
and reduce risk through lower mammalian toxicities leading to higher NOAELs and LOAELs. The 
driving factor in determining hazard is the RfD, derived from NOAELs and LOAELs. Pesticides 
with low mammalian toxicities tend to have higher RfDs, so an exposure must be greater to 
reach a level of concern. However, the low use rates of these reduced risk compounds mean 
exposures are typically low. These two factors work in tandem to keep the hazard from reduced 
risk pesticides low. 
4.11 Conclusions 
     Dislodgeable foliar residues (DFR) declined 37% (carfentrazone-ethyl) to 4.3-fold 
(imidacloprid) between hours 0.25 and 1. A 1-hour re-entry for golf courses would reduce golfer 
exposure and hazard by avoiding play at the time when the residues are the highest. Post-
application irrigation reduces DFR (~ 20-fold for cyfluthrin) and therefore exposure. Irrigation is 
not always an appropriate management tool as its use is dictated by the target pest (e.g., 
subsurface insects and fungi) and the application of pre-emergent herbicides. 
     The hands and ankle/calf received the greatest exposure in our volunteers. The ankle/calf are 
frequently splashed with water and its associated pesticides while the golfers were walking on 
the turf particularly during times of heavy dew and following post-application irrigation. The 
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hands come into direct contact with the turf through placing and removing tees, picking up 
divots, and picking up and marking the ball on the green. Additionally, golfers sometimes lay 
their clubs down on the treated turf, where the grips pick up residues, which are then available 
to be transferred to the hand.   
     Aside from chlorothalonil, airborne residues contributed very little to the overall dose. The 
majority of the dose was dermal in these cases. These pesticides all had low volatility, so it is 
unlikely that they were inhaled in the vapor phase, and were probably sorbed to dust or aerosol 
particles. Chlorothalonil has a very low dermal penetration rate (0.15%), and a high application 
rate 12.7 kg a.i./ha. This application rate is 5.7-fold higher than the next lowest rate, 2.24 kg 
a.i./ha for halofenozide, and 20.1-fold higher than the third-highest application rate, 0.61 kg 
a.i./ha for azoxystrobin. This high application rate means that there was most likely a great deal 
of chlorothalonil associated with dust subsequently picked up by our personal air samplers. 
     There is good agreement between the dosimetry and biomonitoring data for 2,4-D and 
MCPP-p. This correlation indicates that the use of dosimetry is a valid method of determining 
exposure when biomonitoring is impractical, such as when no toxicokinetic information is 
available, metabolite standards are not available, there are no urinary metabolites, or they are 
not sufficiently abundant. 
     The use of reduced risk pesticides with their lower application rates and diminished 
mammalian toxicity have been shown to reduce hazard to golfers when compared to 
conventional pesticides. MOEs of reduced risk pesticides were 2.7-fold to 774-fold greater than 
their conventional counterparts, indicating a greater margin of safety. 
    Golfer hazard from exposure to 2,4-D, azoxystrobin, carfentrazone-ethyl, chlorothalonil, 
cyfluthrin, halofenozide, imidacloprid and MCPP-p were well below the USEPA acute HQs, and 
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well above the level of concern using the USEPA acute MOE assessment, indicating minimal 
concern from these exposures. 
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